September 2026
1. VICHOS T, Strepkos D, Alexandrou M, Carvalho PEP, et al
   Temporal trends in retrograde crossing of epicardial collaterals in chronic total occlusion percutaneous coronary intervention.
   Int J Cardiol. 2026;459:134586.
   

   >> Share

   
   
2. TERINGOVA E, Molnar R, Saal B, Soosova I, et al
   Transforming post-STEMI care: The IMPACS study design and baseline patient profile.
   Int J Cardiol. 2026;459:134573.
   

   >> Share

   
   
3. CAMILLERI W, Ntantou E, Kloosterman AV, Daemen J, et al
   Ostial vs proximal stenting in LAD stenosis: A comparative study.
   Int J Cardiol. 2026;459:134575.
   

   >> Share

   
   August 2026
4. ISHII Y, Watabe H, Usami K, Terauchi T, et al
   Association between coronary high-intensity plaque and pericoronary adipose tissue attenuation and plaque morphology.
   Int J Cardiol. 2026;457:134552.
   

   >> Share

   
   
5. ALARFAJ M, Mohamad Alahmad MA, Wallisch WJ, Flynn BC, et al
   ELSO-score: A practical pre-ECMO risk model for predicting in-hospital mortality in patients receiving VA-ECMO.
   Int J Cardiol. 2026;457:134542.
   

   >> Share

   
   
6. PESCE F, Dini CS, Righini FM, Stefanini A, et al
   Optimizing cardiogenic shock outcomes: A system-based network approach.
   Int J Cardiol. 2026;457:134535.
   

   >> Share

   
   
7. GADELMAWLA AF, Taha AM, Alkuwaiti FA, Alkuwaiti MA, et al
   Prognostic impact of persistent microvascular obstruction on cardiac magnetic resonance after STEMI: A systematic review and meta-analysis.
   Int J Cardiol. 2026;456:134523.
   

   >> Share

   
   
8. KROLL C, Hubert A, Saccardi L, Martinez Pereyra V, et al
   (Long-term) efficacy of endotype-based drug therapy on quality of life and symptom management in coronary vasomotion disorders.
   Int J Cardiol. 2026;456:134518.
   

   >> Share

   
   
9. GIOVACHINI L, Ferrante A, Guedeney P, Rahoual G, et al
   Impacts of stent characteristics on periprocedural ischemic events in elective PCI: the ALPHEUS-stents study.
   Int J Cardiol. 2026;456:134506.
   

   >> Share

   
   July 2026
10. WU JY, Lee KW, Huang SC, Chang HY, et al
    Association between Ranolazine use and outcomes in patients with suspected MINOCA: A propensity-matched cohort study.
    Int J Cardiol. 2026;455:134504.
    

    >> Share

    
    
11. FREENE N, Seymour J, McPhail SM, Tyack Z, et al
    Frequency of a very brief intervention to increase physical activity levels in cardiac rehabilitation attendees: The 'Measure It!' Multicentre randomised trial.
    Int J Cardiol. 2026;455:134480.
    

    >> Share

    
    
12. NGUYEN KD, Vu VH, Duong BT, Tran H, et al
    Percutaneous coronary intervention registries in the Asia-Pacific region: A systematic review of methodology and patient characteristics and meta-analysis of in-hospital mortality rate.
    Int J Cardiol. 2026;454:134453.
    

    >> Share

    
    
13. JIANG T, Chen C, Shao M, Ma J, et al
    The inflammation-microvascular axis in prognosis: Integrated FAI and AMR assessment for risk stratification after PCI in NSTEMI patients.
    Int J Cardiol. 2026;454:134455.
    

    >> Share

    
    
14. LIU J, Lyu Q, Li J, He X, et al
    Low-dose telmisartan protects against myocardial ischemia/reperfusion injury via dual mechanisms: AMPK activation and AMPK-independent calcium homeostasis.
    Int J Cardiol. 2026;454:134450.
    

    >> Share

    
    June 2026
15. CUI L, Zhao J, Gao Y, Chen Y, et al
    Plaque characteristics and clinical outcomes of non-culprit long lesions in patients with acute myocardial infarction.
    Int J Cardiol. 2026 Jun 17:134627. doi: 10.1016/j.ijcard.2026.134627.
    

    >> Share

    
    
16. ANGIOLILLO DJ, Erlinge D, Gale CP, Gorog DA, et al
    Real-world adoption of the 2023 European Society of Cardiology guidelines regarding antiplatelet strategies in acute coronary syndromes: Insights from the European READAPT-2 survey.
    Int J Cardiol. 2026;453:134288.
    

    >> Share

    
    
17. DI SERAFINO L, Ciaramella L, De Rosa S, Torella D, et al
    Inhibition of late sodium current (INa) to prevent coronary MICROvascular dysfunction in patients presenting with ST-elevation myocardial infarction and multivessel disease: A phase IIb multicenter, randomized, controlled and open label study (INaMICR
    Int J Cardiol. 2026 Jun 11:134620. doi: 10.1016/j.ijcard.2026.134620.
    

    >> Share

    
    
18. YAMAMOTO MH, Mizukami T, Mori H, Kobayashi N, et al
    Impact of absolute stent expansion on two-year clinical outcomes after PCI in patients with acute coronary syndrome: Results from the OCT-guided PCI registry (TACTICS registry).
    Int J Cardiol. 2026;452:134263.
    

    >> Share

    
    May 2026
19. ROBINSON K, Hung J, Wright FL, Katzenellenbogen JM, et al
    Characteristics, readmission patterns and trends in hospitalisations for chronic coronary disease in Western Australia, 2005 to 2022.
    Int J Cardiol. 2026 May 27:134589. doi: 10.1016/j.ijcard.2026.134589.
    

    >> Share

    
    
20. YOSOFI B, Zelis JM, Raafs A, Teeuwen K, et al
    Traditional left ventricular indices outperform novel cardiovascular magnetic resonance-derived left atrial parameters in predicting adverse left ventricular remodelling after ST-segment elevation myocardial infarction.
    Int J Cardiol. 2026;459:134587.
    

    >> Share

    
    
21. BUTT H, van Beek K, Sajjad U, Ibrahim A, et al
    Pre-perfusion coronary wedge pressure and microvascular obstruction in anterior ST elevation myocardial infarction (STEMI): An analysis from the EUROICE study.
    Int J Cardiol. 2026;459:134558.
    

    >> Share

    
    
22. SKI CF, Thompson DR, Jennings CS, Kotseva K, et al
    Female sex is independently associated with poor health-related quality of life in patients with coronary heart disease across 14 countries: the INTERASPIRE study.
    Int J Cardiol. 2026 May 20:134563. doi: 10.1016/j.ijcard.2026.134563.
    

    >> Share

    
    
23. KUBIK S
    Prognostic significance of provocation spasm testing in patients with myocardial infarction with and without obstructive coronary arteries.
    Int J Cardiol. 2026 May 20:134572. doi: 10.1016/j.ijcard.2026.134572.
    

    >> Share

    
    
24. CHENG A, Wu Y, Mou F, Zhou J, et al
    Drug-coated balloon versus drug-eluting stent for treating de novo proximal left anterior descending artery lesions: Insights from the REC-CAGEFREE I trial.
    Int J Cardiol. 2026;451:134267.
    

    >> Share

    
    
25. GHETTI G, Taglieri N, Guiducci V, Capecchi A, et al
    Bail-out stenting and target-vessel failure after drug-coated balloon percutaneous coronary angioplasty for de novo lesions: The BOSS study.
    Int J Cardiol. 2026;451:134250.
    

    >> Share

    
    
26. LOMBARDI M, Chiabrando JG, Occhipinti G, Elia E, et al
    Long term outcomes of different revascularization strategies in left main coronary artery: a network meta-analysis.
    Int J Cardiol. 2026;457:134539.
    

    >> Share

    
    
27. HUA M, Liang R, Nie W, Zhou L, et al
    Novel insights into myocardial synchrony: A CMR-based approach for improving the detection of coronary artery disease at rest.
    Int J Cardiol. 2026;450:134221.
    

    >> Share

    
    
28. PRATI F, Biccire FG, Mallus MT, Mastroianni F, et al
    Coronary inflammation: Identification, clinical impact and possible therapeutical solutions.
    Int J Cardiol. 2026;450:134229.
    

    >> Share

    
    
29. CAI ML, Shi WX, Li J, Li T, et al
    Phase III cardiac rehabilitation improves left ventricular ejection fraction in patients with coronary artery disease and mildly reduced ejection fraction after percutaneous coronary intervention.
    Int J Cardiol. 2026;450:134219.
    

    >> Share

    
    
30. CHIOTIS S, Giannopoulos G, Boulmpou A, Zgouridou A, et al
    Association of common risk factors with major adverse cardiac events and mortality in patients with MINOCA: A systematic review and meta-analysis.
    Int J Cardiol. 2026;450:134225.
    

    >> Share

    
    
31. WOUDSTRA J, Dimitriu-Leen AC, Crooijmans C, Yosofi B, et al
    Microvascular vasomotor dysfunction is more prevalent in female versus epicardial vasomotor dysfunction in male ANOCA patients.
    Int J Cardiol. 2026;450:134226.
    

    >> Share

    
    April 2026
32. DEL TORTO A, Ventura E, Cannata F, Celeste F, et al
    Cardiac magnetic resonance in acute myocardial infarction undergoing thrombus aspiration.
    Int J Cardiol. 2026 Apr 30:134537. doi: 10.1016/j.ijcard.2026.134537.
    

    >> Share

    
    
33. POLLER A, Jha S, Thorleifsson SJ, Espinosa AS, et al
    Left ventricular diastolic function over the acute and subacute phase in the Takotsubo syndrome versus ST-elevation myocardial infarction.
    Int J Cardiol. 2026;456:134522.
    

    >> Share

    
    
34. AYAYO SA, Mamas MA
    Evolving epidemiology and improving outcomes in acute myocardial infarction: Lessons from 25 years of population-level data.
    Int J Cardiol. 2026;456:134511.
    

    >> Share

    
    
35. BO K, Qu T, Wang H, Yue X, et al
    Deep learning-based non-contrast cine CMR for optimized prediction of left ventricular adverse remodeling after ST-elevation myocardial infarction.
    Int J Cardiol. 2026 Apr 22:134499. doi: 10.1016/j.ijcard.2026.134499.
    

    >> Share

    
    
36. YUAN W, Guo Y, Xu R
    Editorial to "Radiomics with native T1 mapping for contrast-free detection of acute and chronic myocardial infarction: A multicenter study".
    Int J Cardiol. 2026 Apr 20:134501. doi: 10.1016/j.ijcard.2026.134501.
    

    >> Share

    
    
37. LARA-GONZALEZ M, Munoz P, Pedraz-Prieto A, Delgado-Montero A, et al
    Prognostic impact of previous and new myocardial infarction in patients with infective endocarditis.
    Int J Cardiol. 2026;456:134508.
    

    >> Share

    
    
38. LOU Q, Bai R, Li L, Lu B, et al
    Targeting ADAMTS4 aggravates myocardial ischemia-reperfusion injury by impairing endothelial integrity and accelerating leukocyte infiltration.
    Int J Cardiol. 2026;449:134195.
    

    >> Share

    
    
39. FEZZI S, Zhu Y, Bargary N, Ding D, et al
    Predicting functional results of percutaneous coronary intervention using machine learning modelling.
    Int J Cardiol. 2026;449:134183.
    

    >> Share

    
    
40. JIN S, Liu W, Chen X, Guo W, et al
    Caveolin-3 serves as a therapeutic target for myocardial ischemia-reperfusion injury in cardiac surgery patients.
    Int J Cardiol. 2026;449:134179.
    

    >> Share

    
    
41. ABUMAYYALEH M, Behnes M, Akin I, Schupp T, et al
    Is the obesity paradox overstated? The underrecognized role of inflammation in myocardial infarction.
    Int J Cardiol. 2026 Apr 10:134479. doi: 10.1016/j.ijcard.2026.134479.
    

    >> Share

    
    
42. DE Y, Han Y, Song Y, Zhang X, et al
    Joint effects of pulse pressure and LVEF on 12-month mortality in acute coronary syndrome patients undergoing PCI.
    Int J Cardiol. 2026;448:134174.
    

    >> Share

    
    
43. ROSENTHAL LM, Yavasca E, Miera O, Krauss A, et al
    Optical coherence tomography for early detection of cardiac allograft vasculopathy in pediatric heart recipients.
    Int J Cardiol. 2026;448:134146.
    

    >> Share

    
    March 2026
44. PERAZA DELGADO AD, Edel PG, Rodriguez IM, Ferrer MF, et al
    Evolution of the risk of death during hospitalization for myocardial infarction in the regions of Spain between the periods 2007-2014 and 2018-2023.
    Int J Cardiol. 2026 Mar 18:134435. doi: 10.1016/j.ijcard.2026.134435.
    

    >> Share

    
    
45. BILATO C, Girardi G, Zuin M, Salmaso L, et al
    Temporal trend in epidemiology and performance indicators of acute myocardial infarction: A 25 years population-based study.
    Int J Cardiol. 2026 Mar 18:134434. doi: 10.1016/j.ijcard.2026.134434.
    

    >> Share

    
    
46. GUO Y, Song X, Xu T, Guo H, et al
    Utilizing machine learning in echocardiographic analysis to distinguish obstructive and non-obstructive coronary artery disease.
    Int J Cardiol. 2026;447:134121.
    

    >> Share

    
    
47. HAKIM D, Ahmed M, Koo C, Coskun AU, et al
    Role of endothelial shear stress metrics in the development and eruption of coronary calcified nodules.
    Int J Cardiol. 2026;447:134117.
    

    >> Share

    
    
48. COSENTINO N, Velato L, Bonomi A, Morocutti C, et al
    Severe obesity and in-hospital outcomes in acute myocardial infarction: Insights into the role of systemic inflammation.
    Int J Cardiol. 2026 Mar 10:134287. doi: 10.1016/j.ijcard.2026.134287.
    

    >> Share

    
    
49. OZAWA T, Goto K, Hirokane A, Mizuno T, et al
    Prognostic significance of provocative spasm tests in patients with myocardial infarction with and without obstructive coronary arteries.
    Int J Cardiol. 2026;452:134277.
    

    >> Share

    
    
50. SAKAI A, Nagao M, Yamamoto A, Nakao R, et al
    Prognostic value of (13)N-ammonia positron emission tomography-derived myocardial strain ratio in ischemia with non-obstructive coronary arteries.
    Int J Cardiol. 2026;446:134094.
    

    >> Share

    
    
51. HOEK R, de Winter RW, Planken NR, Somsen YBO, et al
    Non-invasive hybrid functional and anatomical imaging for guiding revascularization decision-making by the heart team in patients with prior coronary artery bypass grafting.
    Int J Cardiol. 2026;446:134086.
    

    >> Share

    
    
52. CHANDRA P, Sharma YP, Kapoor R, Singhal R, et al
    The TRANSEVER registry - A prospective, open-label, multicentre, post market surveillance study of ISAR SUMMIT polymer-free Everolimus eluting stent in a real-world Indian population of patients with coronary artery disease: One-year outcomes of the f
    Int J Cardiol. 2026;446:134067.
    

    >> Share

    
    
53. MARZILLI M, Gowdak LHW, Sobhy M, Mittal S, et al
    Early combination therapy with trimetazidine rapidly improves symptoms and quality of life in patients recently diagnosed with stable angina: The COMBINE angina study.
    Int J Cardiol. 2026;446:134050.
    

    >> Share

    
    February 2026
54. SANS-ROSELLO J, Fernandez-Peregrina E, Kuku KO, Torres-Ruiz G, et al
    Timing of cardiogenic shock and clinical outcomes in takotsubo syndrome: A multicenter cohort study.
    Int J Cardiol. 2026 Feb 27:134270. doi: 10.1016/j.ijcard.2026.134270.
    

    >> Share

    
    
55. TAN C, Eaves S, Lo A, Mallouhi M, et al
    Diastolic dysfunction assessed by the 2025 American Society of Echocardiography guidelines and survival following myocardial infarction.
    Int J Cardiol. 2026;451:134246.
    

    >> Share

    
    
56. LI S, Huo H, Zheng Y, Liu S, et al
    Radiomics with native T1 mapping for contrast-free detection of acute and chronic myocardial infarction: A multicenter study.
    Int J Cardiol. 2026 Feb 17:134222. doi: 10.1016/j.ijcard.2026.134222.
    

    >> Share

    
    
57. HOTCHI Y, Tanaka R, Kojima Y, Shiozaki M, et al
    Validation of the 0/1-hour cardiac myosin-binding protein C algorithm and establishment of sex-specific reference limits in a Japanese population.
    Int J Cardiol. 2026;445:134082.
    

    >> Share

    
    
58. SLEGERS DPJ, Bova R, Heuts SFM, Betti M, et al
    Diffuse coronary artery disease leads to deferral of both surgical and percutaneous coronary artery revascularisation.
    Int J Cardiol. 2026;445:134049.
    

    >> Share

    
    
59. BRUCATO F, Tognola C, Moreo A, Bellomare M, et al
    Eligibility for Icosapent ethyl in patients undergoing cardiac rehabilitation: A real-world cohort study.
    Int J Cardiol. 2026;445:134046.
    

    >> Share

    
    
60. DE VITA A, Marino AG, Cambise N, Lamendola P, et al
    Coronary microvascular dysfunction in patients with acute coronary syndrome and non-obstructive coronary artery disease: a 10-year clinical follow-up study.
    Int J Cardiol. 2026;445:134031.
    

    >> Share

    
    
61. HADA M, Hoshino M, Watanabe T, Usui E, et al
    Determinants and prognostic significance of microvascular resistance reserve stratified by functional severity of epicardial stenosis.
    Int J Cardiol. 2026;445:134027.
    

    >> Share

    
    
62. JAMAL J, Yang K, Ediriweera T, O'Loughlin A, et al
    Early and late outcomes of patients presenting with STEMI in the absence of standard modifiable risk factors: a reperfusion strategy aggregated analysis.
    Int J Cardiol. 2026;445:134008.
    

    >> Share

    
    
63. LECHNER I, Reindl M, Metzler B, Reinstadler SJ, et al
    PCSK9 and residual risk after ST-elevation myocardial infarction.
    Int J Cardiol. 2026;450:134231.
    

    >> Share

    
    
64. MASCIA G, Cammarano M, Palmieri V, Monti R, et al
    Coronary CT angiography in master athletes: Redefining primary prevention of ischemic heart disease behind the Italian 2023 COCIS guidelines.
    Int J Cardiol. 2026 Feb 2:134214. doi: 10.1016/j.ijcard.2026.134214.
    

    >> Share

    
    
65. CANEDO E, Carrillo-Suarez X, Fernandez-Nofrerias E, Rodriguez-Leor O, et al
    Association between activated clotting time and TIMI flow in STEMI patients pre-treated with unfractionated heparin.
    Int J Cardiol. 2026;444:134007.
    

    >> Share

    
    
66. MOLNAR D, Knuuti J, Bax JJ, Saraste A, et al
    Sex differences in plaque burden and outcomes in symptomatic patients with suspected coronary artery disease.
    Int J Cardiol. 2026;444:134023.
    

    >> Share

    
    
67. CHERBI M, Roubille F, Lamblin N, Puymirat E, et al
    Cardiogenic shock: Who benefits from heart replacement therapy?
    Int J Cardiol. 2026;444:134003.
    

    >> Share

    
    
68. PEREA-ARMIJO J, Herrera-Flores J, Suarez de Lezo-Herreros de Tejada J, Hidalgo-Lesmes FJ, et al
    Inverted provisional in the left main: A therapeutic alternative in ostial circumflex lesions.
    Int J Cardiol. 2026;444:133994.
    

    >> Share

    
    
69. BESUTTI M, Guillon B, Barthod C, Ecarnot F, et al
    Diagnostic yield of referring patients for invasive coronary angiography primarily based on high CAC scores: Positive predictive value for obstructive coronary artery disease in a consecutive real-life cohort.
    Int J Cardiol. 2026;444:133979.
    

    >> Share

    
    January 2026
70. IKEDA A, Fukushima K, Ishii S, Endo K, et al
    Assessment of left ventricular mechanical synchrony and intraventricular blood flow energy in ischemic heart disease using a hybrid positron emission tomography-magnetic resonance system.
    Int J Cardiol. 2026;449:134200.
    

    >> Share

    
    
71. SOUSA RB, Lima MR, Lopes PM, Freitas P, et al
    Impact of using the 2024 ESC guideline-recommended method to estimate the likelihood of obstructive coronary disease - a cardiac CT study.
    Int J Cardiol. 2026;449:134209.
    

    >> Share

    
    
72. DING X, Dang W, Li W, Wang M, et al
    Impact of G protein-coupled receptor autoantibodies on clinical outcomes in patients with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2026 Jan 18:134185. doi: 10.1016/j.ijcard.2026.134185.
    

    >> Share

    
    
73. HAYEK A, Leboube S, Brun C, Moulin F, et al
    CSK9 is a predictive biomarker of major adverse events after acute myocardial infarction.
    Int J Cardiol. 2026 Jan 12:134176. doi: 10.1016/j.ijcard.2026.134176.
    

    >> Share

    
    
74. GIACOBBE F, D'Ascenzo F
    Embracing heterogeneity after myocardial infarction: beyond STEMI and NSTEMI towards a personalized cardiovascular care.
    Int J Cardiol. 2026;448:134167.
    

    >> Share

    
    
75. CHIUSOLO S, Masini G, Zywicki V, Bort IR, et al
    High-intensity versus very-high-intensity statin, both on top of ezetimibe, in acute myocardial infarction: A pragmatic randomized study.
    Int J Cardiol. 2026;448:134140.
    

    >> Share

    
    
76. COERKAMP CF, Hinderks MJ, Elias J, van Veelen A, et al
    Effect of percutaneous coronary intervention for chronic total occlusion on diastolic atrioventricular coupling in ST-elevation myocardial infarction patients.
    Int J Cardiol. 2026;448:134154.
    

    >> Share

    
    
77. HONDA S, Noguchi T
    A step back in time, or a call to action? Revisiting cardiology-unit access in modern acute myocardial infarction treatment.
    Int J Cardiol. 2026 Jan 6:134144. doi: 10.1016/j.ijcard.2025.134144.
    

    >> Share

    
    
78. VON OSMANSKI BI, Ankarfeldt MZ, Olsen NT, Mouridsen MR, et al
    Ten clinically important subgroups of myocardial infarction survivors: Identification by latent class analysis.
    Int J Cardiol. 2026 Jan 6:134139. doi: 10.1016/j.ijcard.2025.134139.
    

    >> Share

    
    
79. KHALED S, Tantawi W, Ahmed WE, Shaikh M, et al
    The impact of post discharge virtual cardiac remote monitoring for patients with acute coronary syndrome during HAJJ season 1445H- KAMC experience.
    Int J Cardiol. 2026;442:133900.
    

    >> Share

    
    
80. SAMY M, Allali A, Alotaibi S, Toelg R, et al
    Serial quantitative flow ratio measurements of a successfully recanalized coronary chronic total occlusion.
    Int J Cardiol. 2026;442:133897.
    

    >> Share

    
    
81. YANG X, Li B, Chen H, Ding R, et al
    CCTA-quantified pericornary inflammation and lipoprotein (a): Combined predictive value in non-obstructive CAD.
    Int J Cardiol. 2026;442:133887.
    

    >> Share

    
    
82. MORENO R, Baptista SB, Rivero-Santana B, Valencia J, et al
    Benefit of coronary stenting using available intracoronary tools in high-risk patients. The OPTI-XIENCE study.
    Int J Cardiol. 2026;442:133847.
    

    >> Share

    
    
83. AL QARAGHULI A, Chitturi KR, Kumar S, Cellamare M, et al
    Exploring the impact of age on microvascular function: Insights from the Coronary Microvascular Disease Registry.
    Int J Cardiol. 2026;442:133858.
    

    >> Share

    
    
84. RUMIZ E, Rivero F, Perez A, Nau G, et al
    ESP-INOCA: Rationale and design of a national multicentre registry for prognostic stratification in patients with suspected myocardial ischaemia and non-obstructive coronary arteries.
    Int J Cardiol. 2026;442:133845.
    

    >> Share

    
    
85. SHOJAZADEH A, Hadjiabdolhamid N, Lee C, Antunes IM, et al
    Early detection of coronary artery disease using low-dose CT perfusion: An experimental western fat diet study.
    Int J Cardiol. 2026;442:133793.
    

    >> Share

    
    December 2025
86. CHEN X, Bao Y, Wang J
    Reinterpreting interleukin-1 receptor antagonist elevation in acute myocardial infarction.
    Int J Cardiol. 2025;441:133697.
    

    >> Share

    
    
87. ZHANG R, Jiang B, Zhao W, Liu J, et al
    A combined radiomics-clinical model for early detection of coronary plaque development in coronary CT angiography-negative populations.
    Int J Cardiol. 2025;441:133778.
    

    >> Share

    
    
88. MASUDA Y, Takeshita R, Tsujimoto A, Sahashi Y, et al
    Automated coronary artery segmentation / tissue characterization and detection of lipid-rich plaque: An integrated backscatter intravascular ultrasound study.
    Int J Cardiol. 2025;441:133744.
    

    >> Share

    
    
89. BENEDETTI A, Fusi C, Coeman M, Ghafari C, et al
    Deferred revascularization of left main stenosis based on instantaneous wave-free ratio: Long-term clinical outcomes from the PHYNAL registry.
    Int J Cardiol. 2025;441:133745.
    

    >> Share

    
    
90. DILENA DD, Huang J, Rauchwerger AS, Reed ME, et al
    Identifying low-risk patients within the observation zone of a 0/2-h high-sensitivity troponin diagnostic protocol for chest pain evaluation.
    Int J Cardiol. 2025;440:133730.
    

    >> Share

    
    
91. LI S, Bo K, Ma W, Li W, et al
    Impact of metabolic dysfunction-associated fatty liver disease on left ventricular function and myocardial strain in patients with ASTEMI: Insights from a 3.0-T cardiac magnetic resonance study.
    Int J Cardiol. 2025;440:133709.
    

    >> Share

    
    
92. LIU C, Yang F, Hu Y, Wang L, et al
    Relationship between coronary artery calcification and plaque vulnerability, a qualitative and quantitative optical coherence tomography study.
    Int J Cardiol. 2025;440:133707.
    

    >> Share

    
    
93. KOCH T, Tauchmann L, Cassese S, Xhepa E, et al
    Long-term safety and efficacy of rotational atherectomy for lesion preparation of calcified coronary lesions.
    Int J Cardiol. 2025;440:133711.
    

    >> Share

    
    
94. RALLIDIS LS, Tsamoulis D, Papathanasiou KA, Kalogeras P, et al
    Eligibility for icosapent ethyl 1-3 months after acute coronary syndrome and the risk for myocardial re-infarction: Data from the CALLINICUS-Hellas Registry.
    Int J Cardiol. 2025;440:133684.
    

    >> Share

    
    November 2025
95. DE LUCA L, Raone L, Rosato S, D'Errigo P, et al
    The prognostic role of cardiology management during index admission for acute myocardial infarction: A nationwide administrative dataset analysis.
    Int J Cardiol. 2025 Nov 28:134069. doi: 10.1016/j.ijcard.2025.134069.
    

    >> Share

    
    
96. AHMAD O, Ibrahim R, Pham HN, Abdelnabi M, et al
    Early glucagon-like peptide-1 receptor agonist use after myocardial infarction in patients with type 2 diabetes.
    Int J Cardiol. 2025 Nov 24:134042. doi: 10.1016/j.ijcard.2025.134042.
    

    >> Share

    
    
97. ZHANG W, Chen Y, Zhu L, Peng S, et al
    Prognostic value of the FIB-4 index in patients with myocardial infarction with non-obstructive coronary arteries.
    Int J Cardiol. 2025;445:134045.
    

    >> Share

    
    
98. EGGERS KM, Hamilton E, Jernberg T, Lindahl B, et al
    Predictors of depressed left-ventricular ejection fraction after acute myocardial infarction.
    Int J Cardiol. 2025 Nov 24:134040. doi: 10.1016/j.ijcard.2025.134040.
    

    >> Share

    
    
99. DAYAWANSA NH, Vogrin S, Zheng WC, Lefkovits J, et al
    Safety and performance of complex percutaneous coronary intervention in centres with and without on-site cardiac surgery: A multi-centre Australian study.
    Int J Cardiol. 2025 Nov 17:134032. doi: 10.1016/j.ijcard.2025.134032.
    

    >> Share

    
    
100. GIACOBBE F, Bruno F, Giannino G, Angelini F, et al
     Safety and efficacy of P2Y12 inhibitors in acute coronary syndromes patients with KDIGO stage IV-V renal disfunction not on dialysis: a subanalysis of the CORALYS registry.
     Int J Cardiol. 2025;439:133613.
     

     >> Share

     
     
101. TOGNOLA C, Bernasconi D, Intravaia RCM, Brioschi G, et al
     Prevalence of hypertriglyceridemia and its association with extreme cardiovascular risk in patients with acute and chronic coronary syndrome enrolled in a cardiac rehabilitation program.
     Int J Cardiol. 2025;439:133608.
     

     >> Share

     
     
102. LI F, Zhang JJ, Ruan GJ, Zhan YY, et al
     Prediction models for no-reflow phenomenon after PCI in acute coronary syndrome patients: A systematic review.
     Int J Cardiol. 2025;439:133603.
     

     >> Share

     
     
103. XU X, Liu Z, Liu Z, Li Z, et al
     Increased sympathetic outflow induced by ventromedial hypothalamic nucleus activation aggravates cardiac electrophysiology disturbance after myocardial ischemia-reperfusion injury.
     Int J Cardiol. 2025;439:133634.
     

     >> Share

     
     
104. NOGAMI K, Ozcan I, Kanaji Y, Gulati R, et al
     Long-term temporal trend in plaque eccentricity assessed through intravascular ultrasound imaging after heart transplantation.
     Int J Cardiol. 2025;444:134022.
     

     >> Share

     
     
105. GADAGER BB, Tang LH, Sevel C, Doherty P, et al
     Change in exercise capacity after cardiac rehabilitation following coronary heart disease in patients with and without diabetes: A follow-up study.
     Int J Cardiol. 2025;444:134005.
     

     >> Share

     
     
106. PAPAZOGLOU AS, Tsiartas E, Kyriakoulis KG, Moysidis DV, et al
     Prevalence and clinical impact of baseline atherosclerotic vascular disease in patients undergoing transcatheter aortic valve implantation: A meta-analysis.
     Int J Cardiol. 2025;444:134004.
     

     >> Share

     
     
107. KATO T, Suzuki K, Kawashima H, Kato Y, et al
     Changes in syndecan-1 concentration in the coronary sinus immediately after cardiac reperfusion reflect postoperative myocardial injury.
     Int J Cardiol. 2025;438:133564.
     

     >> Share

     
     
108. NEBIOLO M, Kang J, Sandrone S, Kim HK, et al
     Duration of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention for bifurcation lesions: Insights from the ULTRA-BIFURCAT registry.
     Int J Cardiol. 2025;438:133542.
     

     >> Share

     
     
109. HU C
     Cangrelor: A new P2Y12 inhibitor with gender differences.
     Int J Cardiol. 2025;438:133511.
     

     >> Share

     
     October 2025
110. RACHWAN RJ, Chehab O, Bou Chaaya RG, Daher G, et al
     A simple clinical scoring model to predict significant left main/three-vessel disease in non-ST elevation acute coronary syndrome: The MADISON score.
     Int J Cardiol. 2025 Oct 26:133976. doi: 10.1016/j.ijcard.2025.133976.
     

     >> Share

     
     
111. ELSCOT JJ, Kakar H, den Dekker WK, Bennett J, et al
     Immediate versus staged complete revascularization in patients presenting with multivessel disease and ST- or non-ST-segment elevation acute coronary syndrome.
     Int J Cardiol. 2025;437:133496.
     

     >> Share

     
     
112. LIU Y, Fu X, Ai X, Li G, et al
     Carotid Intraplaque neovascularization correlates with coronary atherosclerotic plaque, vulnerability detected by intracoronary optical coherence tomography.
     Int J Cardiol. 2025;437:133495.
     

     >> Share

     
     
113. NAMMAS W, Ajosenpaa I, Maaniitty T, Stenstrom I, et al
     Prognostic utility of hybrid coronary computed tomography angiography and myocardial perfusion imaging in elderly patients with suspected coronary artery disease.
     Int J Cardiol. 2025;437:133493.
     

     >> Share

     
     
114. ZENG L, Hu F, Qin P, Jia T, et al
     Dual energy CT-based Radiomics for identification of myocardial focal scar and artificial beam-hardening.
     Int J Cardiol. 2025;437:133482.
     

     >> Share

     
     
115. LU H, Zhang Y, Yang P, Zhao H, et al
     Novel high-burden thrombus criterion: Thrombectomy plus thrombolysis improves microvascular resistance in myocardial infarction.
     Int J Cardiol. 2025;443:133970.
     

     >> Share

     
     
116. OLAWADE DB, Soladoye AA, Omodunbi BA, Aderinto N, et al
     Comparative analysis of machine learning models for coronary artery disease prediction with optimized feature selection.
     Int J Cardiol. 2025;436:133443.
     

     >> Share

     
     September 2025
117. POLLER A, Bech-Hanssen O, Redfors B
     Reply to "On the puzzling speckle tracking echocardiography/clinical severity dissociation between patients with takotsubo syndrome and anterior ST-elevation myocardial infarction".
     Int J Cardiol. 2025 Sep 17:133910. doi: 10.1016/j.ijcard.2025.133910.
     

     >> Share

     
     
118. BICCIRE FG, Di Pietro R, Tu S, Budassi S, et al
     Predictive value of coronary lesion functional assessment using an OCT computational algorithm in the CLIMA study.
     Int J Cardiol. 2025;435:133410.
     

     >> Share

     
     
119. OCANA G, Michaud K, Magnin V, Van der Wal AC, et al
     Coronary CT angiography-derived pericoronary fat attenuation index: Post-mortem histopathological correlation in fatal plaques.
     Int J Cardiol. 2025;435:133388.
     

     >> Share

     
     
120. LINGAMSETTY SSP, Doma M, Kritya M, Thyagaturu H, et al
     Mechanical outcomes of coronary stenting guided by intravascular ultrasound versus optical coherence tomography: A systematic review and meta-analysis with trial sequential analysis of randomized trials.
     Int J Cardiol. 2025;435:133387.
     

     >> Share

     
     
121. KELLER K, Schmitt VH, Hobohm L, Espinola-Klein C, et al
     Risk factors for myocardial infarction in patients with peripheral artery disease.
     Int J Cardiol. 2025 Sep 11:133898. doi: 10.1016/j.ijcard.2025.133898.
     

     >> Share

     
     
122. LENG L, Liu X, Song C, Ran X, et al
     Intra-aortic balloon pump implantation in early-stage cardiogenic shock reduces 30-day mortality in patients with ventricular septal defect following myocardial infarction.
     Int J Cardiol. 2025 Sep 10:133895. doi: 10.1016/j.ijcard.2025.133895.
     

     >> Share

     
     
123. LOPEZ RI, Morello M, Golino M, Hogwood AC, et al
     Interleukin-1 blockade in patients with ST-segment elevation myocardial infarction with and without history of coronary artery disease.
     Int J Cardiol. 2025 Sep 10:133888. doi: 10.1016/j.ijcard.2025.133888.
     

     >> Share

     
     
124. ALFONSO F, Salamanca J, Rivero F
     Cardiogenic shock after acute myocardial infarction: The importance of adherence to management recommendations.
     Int J Cardiol. 2025;442:133860.
     

     >> Share

     
     
125. MADIAS JE
     On the puzzling speckle tracking echocardiography/clinical severity dissociation between patients with takotsubo syndrome and anterior ST-elevation myocardial infarction.
     Int J Cardiol. 2025 Sep 6:133878. doi: 10.1016/j.ijcard.2025.133878.
     

     >> Share

     
     
126. MANEGAONKAR SM, Effat MA, van de Hoef TP, Lee JM, et al
     Delineating coronary epicardial stenosis status from microvascular dysfunction using pressure-drop coefficient from multicenter ILIAS registry.
     Int J Cardiol. 2025;442:133864.
     

     >> Share

     
     
127. ZHANG X, Jin Q, Li C, Yang J, et al
     Prognostic value of angiography-derived microcirculatory resistance in patients undergoing rotational atherectomy- a multi-center study.
     Int J Cardiol. 2025;434:133322.
     

     >> Share

     
     August 2025
128. NILSEN DWT, Leon De La Fuente R, Gallo P, Naesgaard P, et al
     Reply to: Could interleukin-1 receptor antagonist be a reliable predictor of prognosis in acute myocardial infarction?
     Int J Cardiol. 2025 Aug 22:133812. doi: 10.1016/j.ijcard.2025.133812.
     

     >> Share

     
     
129. TIAN J, Wang Y
     Could interleukin-1 receptor antagonist be a reliable predictor of prognosis in acute myocardial infarction?
     Int J Cardiol. 2025 Aug 21:133811. doi: 10.1016/j.ijcard.2025.133811.
     

     >> Share

     
     
130. POLLER A, Bech-Hanssen O, Redfors B
     Reply to comment on "Global and segmental longitudinal and radial strain in Takotsubo versus ST-elevation myocardial infarction" by Poller et al.
     Int J Cardiol. 2025 Aug 20:133801. doi: 10.1016/j.ijcard.2025.133801.
     

     >> Share

     
     
131. NILSEN DWT, Leon De La Fuente R, Gallo P, Naesgaard P, et al
     Reply to: Letter to the editor: High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients.
     Int J Cardiol. 2025 Aug 19:133807. doi: 10.1016/j.ijcard.2025.133807.
     

     >> Share

     
     
132. LONN A, Carroll SJ, Niyonsenga T, Bauman A, et al
     Reply to comment on associations between change in moderate-to-vigorous physical activity and sedentary behaviour with risk of recurrent cardiovascular events among individuals with coronary heart disease: A prospective cohort study.
     Int J Cardiol. 2025 Aug 17:133800. doi: 10.1016/j.ijcard.2025.133800.
     

     >> Share

     
     
133. DWT N, Leon De La Fuente R, Gallo P, Naesgaard P, et al
     Reply to: Reinterpreting interleukin-1 receptor antagonist elevation in acute myocardial infarction.
     Int J Cardiol. 2025 Aug 17:133797. doi: 10.1016/j.ijcard.2025.133797.
     

     >> Share

     
     
134. LATERRA G, Barbanti M, Rosato S, Biancari F, et al
     Incidence of cardiac ischemic events after transcatheter aortic valve replacement: Results from the OBSERVANT studies.
     Int J Cardiol. 2025 Aug 12:133779. doi: 10.1016/j.ijcard.2025.133779.
     

     >> Share

     
     
135. CHEN J, Yang K
     Comment on "Global and segmental longitudinal and radial strain in Takotsubo versus ST-elevation myocardial infarction" by Poller et al.
     Int J Cardiol. 2025 Aug 9:133760. doi: 10.1016/j.ijcard.2025.133760.
     

     >> Share

     
     
136. ZHU B, Xu Y
     Letter to "Impact of frailty assessment on outcomes in critical acute myocardial infarction: Insights from the hospital frailty risk measure (HFRM)".
     Int J Cardiol. 2025 Aug 8:133724. doi: 10.1016/j.ijcard.2025.133724.
     

     >> Share

     
     
137. ZOU JH, Wang HW, Long JZ, Yang XN, et al
     Unveiling the diagnostic and causal role of hyperlipidemia- and lipophagy-associated genes PLAUR, IVNS1ABP, and QKI in acute myocardial infarction.
     Int J Cardiol. 2025 Aug 7:133635. doi: 10.1016/j.ijcard.2025.133635.
     

     >> Share

     
     
138. BIRTOLO LI, Lattanzio A, Di Pietro G
     Editorial of "Real world comparative effectiveness of angiotensin-neprilysin inhibition versus angiotensin receptor blockers in acute myocardial infarction" to International Journal of Cardiology.
     Int J Cardiol. 2025;440:133705.
     

     >> Share

     
     
139. XIE P, Wang H, Xiao J, Xu F, et al
     Generative AI-powered explainable prediction model: Enhancing early in-hospital mortality alert for patients with acute myocardial infarction.
     Int J Cardiol. 2025 Aug 5:133649. doi: 10.1016/j.ijcard.2025.133649.
     

     >> Share

     
     
140. ZHAO J, Peng Y
     Letter to the editor: High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients are associated with increased rates of all-cause mortality and cardiac death at five years follow-up.
     Int J Cardiol. 2025 Aug 5:133719. doi: 10.1016/j.ijcard.2025.133719.
     

     >> Share

     
     
141. MORONI F, Golino M, Abbate A
     Unopposed inflammation and long-term outcomes after acute myocardial infarction.
     Int J Cardiol. 2025 Aug 4:133710. doi: 10.1016/j.ijcard.2025.133710.
     

     >> Share

     
     
142. YANG Y, Jiao X, Shi J
     Moderate-to-vigorous physical activity and sedentary behavior dynamics in coronary heart disease: modifiable targets or mere risk indicators?
     Int J Cardiol. 2025 Aug 2:133714. doi: 10.1016/j.ijcard.2025.133714.
     

     >> Share

     
     
143. ESMEL-VILOMARA R, Riaza L, Dolader P, Rodriguez-Santiago B, et al
     Infarct-like myocarditis in adolescents: Exploring genetic insights from diagnosis through follow-up.
     Int J Cardiol. 2025;432:133255.
     

     >> Share

     
     July 2025
144. LI L, Tang S, Li Y, Zhou X, et al
     Reply to letter to the editor: Real-world comparative effectiveness of angiotensin-neprilysin inhibition versus angiotensin receptor blockers in acute myocardial infarction.
     Int J Cardiol. 2025;440:133693.
     

     >> Share

     
     
145. LIU Y, Li C, Wang L, Hao X, et al
     Report on the adherence to key management strategies and mortality rates in patients with acute myocardial infarction-related cardiogenic shock: Finding from the improving Care for Cardiovascular Disease in China-acute coronary syndrome project.
     Int J Cardiol. 2025 Jul 26:133666. doi: 10.1016/j.ijcard.2025.133666.
     

     >> Share

     
     
146. DWT N, Leon De La Fuente R, Gallo P, Naesgaard P, et al
     High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients are associated with increased rates of all-cause mortality and cardiac death at five years follow-up.
     Int J Cardiol. 2025;439:133674.
     

     >> Share

     
     
147. POLLER A, Jha S, Molander L, Espinosa AS, et al
     Global and segmental longitudinal and radial strain in Takotsubo versus ST-elevation myocardial infarction.
     Int J Cardiol. 2025;439:133668.
     

     >> Share

     
     
148. YAO Y, Wu Y
     Letter to the editor: Real-world comparative effectiveness of angiotensin-neprilysin inhibition versus angiotensin receptor blockers in acute myocardial infarction.
     Int J Cardiol. 2025 Jul 21:133657. doi: 10.1016/j.ijcard.2025.133657.
     

     >> Share

     
     
149. SUN R, Li L
     The comment on "Associations between changes in moderate-to-vigorous physical activity and sedentary behaviour with recurrent cardiovascular events among individuals with coronary heart disease".
     Int J Cardiol. 2025 Jul 16:133631. doi: 10.1016/j.ijcard.2025.133631.
     

     >> Share

     
     
150. SU X, Qiu M, Liu H, Xu K, et al
     Prolonged dual antiplatelet therapy strategy in acute coronary syndrome patients post-standard therapy and adverse event-free: An analysis based on OPT-CAD risk score stratification.
     Int J Cardiol. 2025;439:133636.
     

     >> Share

     
     
151. DE GREGORIO C, Granata L, Raspanti D, Giannino F, et al
     Cephalosporin triggered Kounis syndrome: Pathophysiological and clinical insights.
     Int J Cardiol. 2025;431:133249.
     

     >> Share

     
     
152. LAMMENS J, Motoc A, Tanaka K, Belsack D, et al
     Favorable impact of FFR(CT) on myocardial revascularization outcomes: Results from an observational real-world registry.
     Int J Cardiol. 2025;431:133245.
     

     >> Share

     
     
153. KUHN L, Akin I, Steinke P, Abumayyaleh M, et al
     Obesity is associated with impaired long-term prognosis in patients undergoing coronary angiography: Results from a large-scaled single centre registry.
     Int J Cardiol. 2025;431:133252.
     

     >> Share

     
     
154. YAMAMOTO K, Saito Y, Tateishi K, Kato K, et al
     Relation between previously implanted coronary stents and vasospasm: Patient- and vessel-level analysis.
     Int J Cardiol. 2025;431:133248.
     

     >> Share

     
     
155. LI Z, Huang S, Li H, Liu Q, et al
     PERK's novel agonist protects against myocardial ischemia-reperfusion injury by modulating ER-mitochondria contacts and phosphatidic acid transport.
     Int J Cardiol. 2025;431:133222.
     

     >> Share

     
     
156. LIU T, Fan Z, Li Y, Xiao B, et al
     Combination treatment of SGLT2i and GLP-1RA associated with improved cardiovascular outcomes in type 2 diabetes patients with acute coronary syndrome: A propensity score-matched cohort study.
     Int J Cardiol. 2025;431:133229.
     

     >> Share

     
     
157. WANG J, Li C, Zhang M, Zhou J, et al
     The performance of angiography-derived index of microcirculatory resistance for ischemia in angina with non-obstructive coronary artery disease: Validated by wire-based IMR and SPECT-MPI.
     Int J Cardiol. 2025;431:133236.
     

     >> Share

     
     
158. ZHU Y, Wang X, Su S, Qiao Z, et al
     Interpretable hybrid-ensemble acute myocardial infarction diagnosis with clinical transparency.
     Int J Cardiol. 2025 Jul 5:133598. doi: 10.1016/j.ijcard.2025.133598.
     

     >> Share

     
     
159. TANG S, Li L, Chen H, Geru A, et al
     Real-world comparative effectiveness of angiotensin-neprilysin inhibition versus angiotensin receptor blockers in acute myocardial infarction.
     Int J Cardiol. 2025 Jul 3:133543. doi: 10.1016/j.ijcard.2025.133543.
     

     >> Share

     
     
160. YINHUA L, Hu Y, Ziyue Z, Zhou J, et al
     Systemic coagulation-inflammation index in the prediction of ISR in patients undergoing drug-eluting stents implant: A retrospective study based on multiple machine learning methods.
     Int J Cardiol. 2025;430:133215.
     

     >> Share

     
     
161. NAMBA HF, Boerhout CKM, Damman P, Kunadian V, et al
     Invasive coronary function testing in clinical practice: Implementing the 2024 ESC guidelines on chronic coronary syndromes.
     Int J Cardiol. 2025;430:133176.
     

     >> Share

     
     
162. FAN C, Yan H, Lei K, Li D, et al
     Association of fasting blood glucose with in-hospital mortality in acute coronary syndrome patients with different glycemic statuses: Findings from the CCC-ACS project.
     Int J Cardiol. 2025;430:133184.
     

     >> Share

     
     
163. TSAI TY, Revaiah PC, Aldujeli A, Miyashita K, et al
     Cumulative plaque burden analysis for phenotyping epicardial coronary artery disease.
     Int J Cardiol. 2025;430:133173.
     

     >> Share

     
     June 2025
164. PEIRO OM, Bardaji A, Carrasquer A, Cediel G, et al
     Reply to "Growth differentiation factor 15 and empagliflozin in acute myocardial infarction: Correspondence".
     Int J Cardiol. 2025;438:133531.
     

     >> Share

     
     
165. CHEN L, Ge L, Abdu FA, Du X, et al
     Prognostic value of CMR-derived extracellular volume in myocardial infarction with non-obstructive coronary arteries.
     Int J Cardiol. 2025;437:133528.
     

     >> Share

     
     
166. ZHANG X, Jin Q, Xue Q
     Reply to: Interplay between angiography-derived microcirculatory resistance and periprocedural myocardial infarction following rotational atherectomy.
     Int J Cardiol. 2025;437:133490.
     

     >> Share

     
     
167. GUARNIERI G, Pozzi FE, Conte E, Righetto M, et al
     Extreme endurance training and coronary artery disease: A systematic review and a meta-analysis.
     Int J Cardiol. 2025;429:133172.
     

     >> Share

     
     
168. BERRY C, Camici PG, Crea F, George M, et al
     Clinical standards in angina and non-obstructive coronary arteries: A clinician and patient consensus statement.
     Int J Cardiol. 2025;429:133162.
     

     >> Share

     
     
169. LONN A, Carroll SJ, Niyonsenga T, Bauman A, et al
     Associations between change in moderate-to-vigorous physical activity and sedentary behaviour with risk of recurrent cardiovascular events among individuals with coronary heart disease: A prospective cohort study.
     Int J Cardiol. 2025;437:133513.
     

     >> Share

     
     
170. SMARZ K, Tysarowski M
     Response to comment on "Low chronotropic response in post-myocardial infarction exercise test predicts worse prognosis in patients with preserved or mildly reduced left ventricular ejection fraction".
     Int J Cardiol. 2025;437:133484.
     

     >> Share

     
     
171. BIASIN M, Cordioli N, Armani I, Guerrieri L, et al
     Lipid profiles in ST-elevation myocardial infarction with and without diabetes: the gap between prescription and targets.
     Int J Cardiol. 2025;437:133474.
     

     >> Share

     
     
172. HAN J, Wang Z, Chen T, Liu S, et al
     Artificial intelligence driven plaque characterization and functional assessment from CCTA using OCT-based automation: A prospective study.
     Int J Cardiol. 2025;428:133140.
     

     >> Share

     
     
173. KUNA C, Bradaric C, Koch T, Presch A, et al
     Age-related ten-year outcomes after percutaneous coronary intervention of in-stent restenosis.
     Int J Cardiol. 2025;428:133109.
     

     >> Share

     
     May 2025
174. GRIFFITH GJ
     Chronotropic incompetence and the importance of cardiopulmonary exercise testing following myocardial infarction.
     Int J Cardiol. 2025 May 31:133445. doi: 10.1016/j.ijcard.2025.133445.
     

     >> Share

     
     
175. CARLSON PE, Schwager S, Feldewerd K, Schmidt S, et al
     The use of supersaturated oxygen therapy in patients with late-presentation anterior ST-segment elevation myocardial infarction.
     Int J Cardiol. 2025;436:133429.
     

     >> Share

     
     
176. AHMAD MH, Bilal M, Ibrahim M, Iman H, et al
     Letter to editor on low chronotropic response in post-myocardial infarction exercise test predicts worse prognosis in patients with preserved or mildly reduced left ventricular ejection fraction.
     Int J Cardiol. 2025 May 27:133432. doi: 10.1016/j.ijcard.2025.133432.
     

     >> Share

     
     
177. GIALLAURIA F, Vigorito C
     Editorial to "Impact of Frailty Assessment on Outcomes in Critical Acute Myocardial Infarction: Insights from the Hospital Frailty Risk Measure (HFRM)", Wu et al., Int J Cardiol. 2025 Apr 22:133294. doi: 10.1016/j.ijcard.2025.133294. Epub ahead of pri
     Int J Cardiol. 2025;435:133418.
     

     >> Share

     
     
178. FERRI N
     "SES", "SESS", or "SVESS" approaches for patients with myocardial infarction.
     Int J Cardiol. 2025;435:133412.
     

     >> Share

     
     
179. LAMELAS P, Sa MP, Izcovich A, Bottaro F, et al
     Percutaneous or surgical revascularization in patients with severe left main coronary artery disease in Latin America: A GRADE clinical practice guideline.
     Int J Cardiol. 2025 May 20:133401. doi: 10.1016/j.ijcard.2025.133401.
     

     >> Share

     
     
180. FROYSA V, Berg GJ, Singsaas E, Eftestol T, et al
     Texture-based probability mapping for automatic assessment of myocardial injury in late gadolinium enhancement images after revascularized STEMI.
     Int J Cardiol. 2025;427:133107.
     

     >> Share

     
     
181. DZIEWIERZ A
     Interplay between angiography-derived microcirculatory resistance and periprocedural myocardial infarction following rotational atherectomy.
     Int J Cardiol. 2025;435:133395.
     

     >> Share

     
     
182. HAIDER A, Imran A
     Comment on "Low chronotropic response in post-myocardial infarction exercise test predicts worse prognosis in patients with preserved or mildly reduced left ventricular ejection fraction".
     Int J Cardiol. 2025;435:133394.
     

     >> Share

     
     
183. ZARRAR M
     Growth Differentiation Factor 15 and Empagliflozin in acute myocardial infarction: Correspondence.
     Int J Cardiol. 2025 May 11:133365. doi: 10.1016/j.ijcard.2025.133365.
     

     >> Share

     
     
184. PETERS EJ, Henriques JPS
     Response to the Letter to the Editor on "Sex disparities in myocardial infarction related cardiogenic shock".
     Int J Cardiol. 2025 May 3:133311. doi: 10.1016/j.ijcard.2025.133311.
     

     >> Share

     
     
185. GUPTA R, Yadav O, Gupta N, Yadav A, et al
     Re: Use of supersaturated oxygen therapy in patients with late-presentation anterior ST-segment elevation myocardial infarction.
     Int J Cardiol. 2025;434:133355.
     

     >> Share

     
     
186. STEITIEH D, Beale R, Katznelson E, Feldman E, et al
     Trends in mechanical circulatory support utilization, left ventricular assist device implantation and transplant during cardiogenic shock hospitalizations, after the new heart allocation policy.
     Int J Cardiol. 2025;426:133054.
     

     >> Share

     
     April 2025
187. PATTI G, Cumitini L, Bosco M, Marengo A, et al
     Impact of a personalized, strike early and strong approach on non-HDL-cholesterol levels and outcome in patients with acute myocardial infarction.
     Int J Cardiol. 2025 Apr 29:133327. doi: 10.1016/j.ijcard.2025.133327.
     

     >> Share

     
     
188. SMARZ K, Tysarowski M, Ziolo J, Zaborska B, et al
     Low chronotropic response in post-myocardial infarction exercise test predicts worse prognosis in patients with preserved or mildly reduced left ventricular ejection fraction.
     Int J Cardiol. 2025;433:133320.
     

     >> Share

     
     
189. WU S, Xu W, Hao B, Lin Z, et al
     Impact of frailty assessment on outcomes in critical acute myocardial infarction: Insights from the hospital frailty risk measure (HFRM).
     Int J Cardiol. 2025 Apr 22:133294. doi: 10.1016/j.ijcard.2025.133294.
     

     >> Share

     
     
190. ABUSNINA W, Chaturvedi A, Chitturi KR, Lupu L, et al
     Gender disparities in cangrelor usage for the treatment of patients with acute coronary syndrome undergoing percutaneous coronary intervention.
     Int J Cardiol. 2025 Apr 12:133280. doi: 10.1016/j.ijcard.2025.133280.
     

     >> Share

     
     
191. RAZAVI SR, Szun T, Zaremba AC, Cheung S, et al
     Predicting prolonged length of in-hospital stay in patients with non-ST elevation myocardial infarction (NSTEMI) using artificial intelligence.
     Int J Cardiol. 2025;432:133267.
     

     >> Share

     
     
192. CARLSON PE, Schwager S, Feldewerd K, Schmidt S, et al
     The use of supersaturated oxygen therapy in patients with late-presentation anterior ST-segment elevation myocardial infarction.
     Int J Cardiol. 2025 Apr 8:133256. doi: 10.1016/j.ijcard.2025.133256.
     

     >> Share

     
     
193. CILIBERTI G, Fortuni F, Santucci A, Timi A, et al
     Temporal trends of characteristics and management of patients with suspected MINOCA.
     Int J Cardiol. 2025;424:133039.
     

     >> Share

     
     March 2025
194. HASAN M, Chola MH
     Comment on"Sex disparities in myocardial infarction related cardiogenic shock".
     Int J Cardiol. 2025;430:133209.
     

     >> Share

     
     
195. YANG X, Wu H, Liu D, Zhou G, et al
     Dynamic glycemic monitoring and systemic inflammation assessment: New insights into plaque characteristics in acute myocardial infarction.
     Int J Cardiol. 2025;430:133189.
     

     >> Share

     
     
196. OLIVERI F, van Oort MJH, Phagu AAS, Al Amri I, et al
     Intravascular lithotripsy in calcified left main coronary artery: Procedural success and 1-year clinical outcomes.
     Int J Cardiol. 2025;423:132996.
     

     >> Share

     
     
197. PEIRO OM, Bardaji A, Carrasquer A, Cediel G, et al
     Growth differentiation factor 15: A biomarker to guide empagliflozin treatment in acute myocardial infarction?
     Int J Cardiol. 2025;429:133167.
     

     >> Share

     
     
198. BILQUEES A, Saleem D, Aamir M
     Constructive feedback on the link between depression and acute myocardial infarction: A response to recent findings.
     Int J Cardiol. 2025;429:133156.
     

     >> Share

     
     
199. SAITO Y, Kobayashi Y
     Endeavor of exploring mechanisms of myocardial infarction in patients with no standard modifiable cardiovascular risk factors.
     Int J Cardiol. 2025;429:133155.
     

     >> Share

     
     
200. ROULE V, Singh M, Trimaille A, Delmas C, et al
     Prevalence of recreational drug use in myocardial infarction patients without standard modifiable risk factors: Insights from a multicenter prospective cohort study.
     Int J Cardiol. 2025 Mar 10:133146. doi: 10.1016/j.ijcard.2025.133146.
     

     >> Share

     
     
201. SIRAW BB, Isha S, Mehadi AY, Tafesse YT, et al
     In-hospital outcomes of cardiogenic shock patients: A propensity score-matched nationwide comparative analysis between intra-aortic balloon pump and percutaneous ventricular assist devices.
     Int J Cardiol. 2025 Mar 3:133093. doi: 10.1016/j.ijcard.2025.133093.
     

     >> Share

     
     
202. GALANTE D, Vicere A, Marrone A, Verardi FM, et al
     Fractional flow reserve (FFR) and index of microcirculatory resistance (IMR) relationship in patients with chronic or stabilized acute coronary syndromes.
     Int J Cardiol. 2025;422:132978.
     

     >> Share

     
     
203. ZHANG M, Chen Q, Cheng K, Zhang W, et al
     Long non-coding RNA XR008038 promotes the myocardial ischemia/reperfusion injury development through increasing the expressions of galectin-3.
     Int J Cardiol. 2025;422:132955.
     

     >> Share

     
     
204. XU J, Luo D, Lei Y, Hu Z, et al
     Correlation between abnormal microvascular perfusion and quantitative flow ratio after primary PCI in patients with STEMI.
     Int J Cardiol. 2025;422:132949.
     

     >> Share

     
     
205. MANDURINO-MIRIZZI A, Munafo AR, Rizzo F, Raone L, et al
     Comparison of different guidance strategies to percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
     Int J Cardiol. 2025;422:132936.
     

     >> Share

     
     February 2025
206. YI L, Quan W, Zhang M, Zhu T, et al
     Corrigendum to "Potential of(68)Ga-FAPI-04 PET/MR to predict worsening renal function after acute ST-elevation myocardial infarction" [International journal of cardiology vol. 414 (2024): 132425].
     Int J Cardiol. 2025;426:133086.
     

     >> Share

     
     
207. NISHI T, Saito Y, Tateishi K, Kobayashi Y, et al
     Safety and clinical implications of coronary spasm provocation testing in patients presenting with myocardial infarction with no overt culprit lesion.
     Int J Cardiol. 2025 Feb 20:133066. doi: 10.1016/j.ijcard.2025.133066.
     

     >> Share

     
     
208. RICKEN KWLM, Lipsic E
     Reply to: Left atrial strain: A newly emerging prognostic marker for ST-elevation myocardial infarction.
     Int J Cardiol. 2025 Feb 18:133071. doi: 10.1016/j.ijcard.2025.133071.
     

     >> Share

     
     
209. YANG Y, Yan Y, Zhou Z, Zhang J, et al
     Accurate prediction of bleeding risk after coronary artery bypass grafting with dual antiplatelet therapy: A machine learning model vs. the PRECISE-DAPT score.
     Int J Cardiol. 2025;421:132925.
     

     >> Share

     
     
210. PETERSON BE, Bhatt DL, Ballantyne CM, de Lemos JA, et al
     Inadequate Intensification of LDL-cholesterol lowering therapy after coronary revascularization: Insights from the GOULD registry.
     Int J Cardiol. 2025;421:132916.
     

     >> Share

     
     
211. DENG C, Liu Z, Zhao R, Shi B, et al
     Intravascular imaging and functional assessment for coronary in-stent restenosis: Current status and future directions.
     Int J Cardiol. 2025;421:132918.
     

     >> Share

     
     
212. OZAKI R, Motoyama S, Ozaki Y, Sarai M, et al
     Impact of CT-angiography derived plaque characteristics on cardiac events in patients with a negative invasive fractional flow reserve.
     Int J Cardiol. 2025;421:132895.
     

     >> Share

     
     
213. KUBICA J, Adamski P, Ostrowska M, Kubica A, et al
     Prolonged antithrombotic treatment after de-escalation of dual antiplatelet therapy in patients after acute coronary syndrome - which strategy should be applied? The ELECTRA-SIRIO 2 investigators standpoint.
     Int J Cardiol. 2025;421:132897.
     

     >> Share

     
     
214. DEMIREL C, Hamzaraj K, Fangl J, Hemetsberger R, et al
     Association of ABO blood group with risk of coronary stent thrombosis.
     Int J Cardiol. 2025;421:132758.
     

     >> Share

     
     
215. MAURINA M, Riche M, Oliva O, Zendjebil S, et al
     Decoding medina 0.0.1 bifurcation: Are all codes equal? Results from a multicentric registry.
     Int J Cardiol. 2025;421:132863.
     

     >> Share

     
     
216. SHAIKH S, Hamza M, Neppala S, Singh S, et al
     Colchicine for secondary prevention in patients with acute coronary syndrome: A systematic review and meta-analysis.
     Int J Cardiol. 2025 Feb 7:133045. doi: 10.1016/j.ijcard.2025.133045.
     

     >> Share

     
     
217. MICHELSEN HO, Henriksson P, Wallert J, Back M, et al
     Retraction notice to "Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction: The Perfect-CR study?" [International journal of Cardiology 371C (2022) 40-48].
     Int J Cardiol. 2025;420:132876.
     

     >> Share

     
     
218. KRAVCHENKO D, Vecsey-Nagy M, Varga-Szemes A, Hagar MT, et al
     Intra-individual radiomic analysis of pericoronary adipose tissue: Photon-counting detector vs energy-integrating detector CT angiography.
     Int J Cardiol. 2025;420:132749.
     

     >> Share

     
     January 2025
219. MO SF, Zeng QP, Yang L
     Left atrial strain: A newly emerging prognostic marker for ST-elevation myocardial infarction.
     Int J Cardiol. 2025 Jan 31:133034. doi: 10.1016/j.ijcard.2025.133034.
     

     >> Share

     
     
220. DE SIO V, Gragnano F, Capolongo A, Guarnaccia N, et al
     Eligibility for and practical implications of Semaglutide in overweight and obese patients with acute coronary syndrome.
     Int J Cardiol. 2025;423:133028.
     

     >> Share

     
     
221. WANG L, Wu H, Wu C, Shu L, et al
     A deep-learning system integrating electrocardiograms and laboratory indicators for diagnosing acute aortic dissection and acute myocardial infarction.
     Int J Cardiol. 2025 Jan 27:133008. doi: 10.1016/j.ijcard.2025.133008.
     

     >> Share

     
     
222. SAITO T, Watanabe A, Aikawa T, Kapur NK, et al
     Comparison of temporary mechanical circulatory support devices for patients with cardiogenic shock after acute myocardial infarction: A network meta-analysis of randomized controlled trials.
     Int J Cardiol. 2025 Jan 25:132997. doi: 10.1016/j.ijcard.2025.132997.
     

     >> Share

     
     
223. CHEN Y, Fang C, Zhao J, Jiang S, et al
     Glycemic control and coronary plaque characteristics in patients with acute myocardial infarction.
     Int J Cardiol. 2025;423:132988.
     

     >> Share

     
     
224. KWOK CS, Borovac JA, Will M, Schwarz K, et al
     Hospitalizations during the 30-day period preceding the admission for the acute ST-elevation myocardial infarction: Insights from the Nationwide Readmission Database (NRD).
     Int J Cardiol. 2025 Jan 16:132991. doi: 10.1016/j.ijcard.2025.132991.
     

     >> Share

     
     
225. BERNTORP K, Mohammad MA, Koul S, Yndigegn T, et al
     Deferral of left main coronary artery revascularization via IVUS or coronary physiology - Long-term outcomes from the SWEDEHEART registry.
     Int J Cardiol. 2025;419:132726.
     

     >> Share

     
     
226. GIGANTE B, Chen Q, Bjorkbacka H, Bjornson E, et al
     Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis.
     Int J Cardiol. 2025;419:132698.
     

     >> Share

     
     
227. SCHAUFELE T, Nobre Menezes M, Schulte Steinberg B, Hubert A, et al
     Effects of radial artery spasm prophylaxis on intracoronary vasomotor responses during acetylcholine spasm provocation testing.
     Int J Cardiol. 2025;419:132703.
     

     >> Share

     
     
228. JENSEN RV, Jensen JM, Iraqi N, Grove EL, et al
     Coronary CT angiography instead of invasive angiography before TAVI: Feasibility and outcomes.
     Int J Cardiol. 2025;419:132694.
     

     >> Share

     
     
229. URIBARRI A, Vazirani R, Delia MA, Tomasino M, et al
     Impact of mechanical circulatory support on outcomes in Takotsubo syndrome complicated by cardiogenic shock: Insights from the RETAKO registry.
     Int J Cardiol. 2025;419:132681.
     

     >> Share

     
     
230. HE P, Chen H, Yang J, Gao L, et al
     The efficacy of an intracoronary cocktail administration in preventing no-reflow during excimer laser coronary angioplasty in patients with in-stent restenosis: A pilot study. (ELCA- cocktail study).
     Int J Cardiol. 2025;419:132666.
     

     >> Share

     
     
231. MOLEDINA SM, Weight N, Cole A, Rashid M, et al
     The impact of specialist cardiology inpatient care on the long-term outcomes of non-ST-segment elevation myocardial infarction (NSTEMI): A nationwide cohort study.
     Int J Cardiol. 2025 Jan 15:132990. doi: 10.1016/j.ijcard.2025.132990.
     

     >> Share

     
     
232. BAUER D, Spanyi SB, Neuberg M, Kocka V, et al
     Myocardial infarction in multivessel disease: Does presence of chronic total occlusion make a difference?
     Int J Cardiol. 2025 Jan 12:132984. doi: 10.1016/j.ijcard.2025.132984.
     

     >> Share

     
     
233. KESTI H, Mattila K, Jaakkola S, Lehto J, et al
     Impact of high bleeding risk and associated risk factors on major adverse cardiovascular or cerebrovascular events in primary percutaneous coronary intervention treated ST-elevation myocardial infarction.
     Int J Cardiol. 2025 Jan 11:132986. doi: 10.1016/j.ijcard.2025.132986.
     

     >> Share

     
     
234. HAKIM D, Ahmed M, Coskun AU, Maynard C, et al
     Spatial patterns of high-risk biomechanical metrics in plaques with abnormal vs. normal physiological flow indices.
     Int J Cardiol. 2025;418:132651.
     

     >> Share

     
     
235. DE JONG EAM, Namba HF, Boerhout CKM, Feenstra RGT, et al
     Assessment of coronary endothelial dysfunction using contemporary coronary function testing.
     Int J Cardiol. 2025;418:132640.
     

     >> Share

     
     
236. NAMBA HF, Boerhout CKM, de Jong EAM, van de Hoef TP, et al
     Aortic versus distal pressure for derivation of hyperaemic microvascular resistance: From the ILIAS registry.
     Int J Cardiol. 2025;418:132632.
     

     >> Share

     
     
237. WOXHOLT S, Ueland T, Aukrust P, Anstensrud AK, et al
     Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI.
     Int J Cardiol. 2025;418:132613.
     

     >> Share

     
     
238. CAHUAPAZA-GUTIERREZ NL, Calderon-Hernandez CC, Chambergo-Michilot D, De Arruda-Chaves E, et al
     Clinical characteristics, management, diagnostic findings, and various etiologies of patients with Kounis syndrome. A systematic review.
     Int J Cardiol. 2025;418:132606.
     

     >> Share

     
     
239. MAHENDIRAN T, Thanou D, Senouf O, Jamaa Y, et al
     AngioPy Segmentation: An open-source, user-guided deep learning tool for coronary artery segmentation.
     Int J Cardiol. 2025;418:132598.
     

     >> Share

     
     
240. GOYAL A, Tariq MD, Shahnoor S, Saeed H, et al
     Short- and long-term outcomes of antegrade versus retrograde approaches in patients undergoing percutaneous coronary intervention for chronic total occlusion: A meta-analysis.
     Int J Cardiol. 2025;418:132590.
     

     >> Share

     
     December 2024
241. STANISLAWSKI R, Aboul-Hassan SS, Pieszko K, Awad AK, et al
     Long-term outcomes of minimally invasive direct coronary artery bypass vs second generation drug eluting stent for management of isolated left anterior descending artery disease.
     Int J Cardiol. 2024;422:132935.
     

     >> Share

     
     
242. FATH AR, Elgendy IY
     Steps towards closing the sex-related disparities in acute myocardial infarction-related cardiogenic shock.
     Int J Cardiol. 2024 Dec 24:132928. doi: 10.1016/j.ijcard.2024.132928.
     

     >> Share

     
     
243. RICKEN KWLM, Lenselink C, Venema CS, van der Horst ICC, et al
     Left atrial strain predicts long-term heart failure outcomes after ST-elevation myocardial infarction.
     Int J Cardiol. 2024 Dec 22:132931. doi: 10.1016/j.ijcard.2024.132931.
     

     >> Share

     
     
244. KATAMINE M, Minami Y, Nagata T, Asakura K, et al
     High-sensitivity C-reactive protein, plaque vulnerability and adverse events in patients with stable coronary disease: An optical coherence tomography study.
     Int J Cardiol. 2024;421:132924.
     

     >> Share

     
     
245. TINDALE A, Elghazaly H, Baker C, Panoulas V, et al
     External validation of the BE-ALIVE score for predicting 30-day mortality in patients presenting with acute coronary syndromes.
     Int J Cardiol. 2024;417:132560.
     

     >> Share

     
     
246. LOUTATI R, Bruoha S, Taha L, Karmi M, et al
     Association between peak troponin level and prognosis among patients admitted to intensive cardiovascular care unit.
     Int J Cardiol. 2024;417:132556.
     

     >> Share

     
     
247. CHO S, Cho H, Min H, Lee JG, et al
     Clinical impact of deep learning-derived intravascular ultrasound characteristics in patients with deferred coronary artery.
     Int J Cardiol. 2024;417:132543.
     

     >> Share

     
     
248. IMPROTA R, Di Pietro G, Piccialuti A, De Filippo O, et al
     Invasive and conservative management of elderly patients presenting with acute coronary syndrome: A meta-analysis of randomized controlled trials and adjusted observational studies.
     Int J Cardiol. 2024;417:132523.
     

     >> Share

     
     
249. WATANABE A, Miyamoto Y, Ueyama H, Gotanda H, et al
     The use of pulmonary artery catheter and clinical outcomes in older adults with cardiogenic shock.
     Int J Cardiol. 2024;417:132509.
     

     >> Share

     
     
250. SUNDQVIST MO, Svensson P, Soderberg S, Bergdahl IA, et al
     Seroprevalence of Helicobacter pylori and incident myocardial infarction - A population-based Swedish nested case-control study.
     Int J Cardiol. 2024 Dec 15:132917. doi: 10.1016/j.ijcard.2024.132917.
     

     >> Share

     
     
251. SIA CH, Ho AFW
     Cardiogenic shock in the setting of acute myocardial infarction: Still a difficult entity to treat.
     Int J Cardiol. 2024;421:132886.
     

     >> Share

     
     
252. QIAN L, Zhang S, Lin C, Lin J, et al
     Depression exacerbates myocardial ischemia-reperfusion injury in mice via CNR2 gene and MIF-AMPK signaling pathway.
     Int J Cardiol. 2024;416:132505.
     

     >> Share

     
     
253. TEIXEIRA L, Ferreira ROM, Navalha DDP, Pasqualotto E, et al
     Intravascular imaging-guided vs. angiography-guided percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials in high-risk patients and complex coronary anatomies.
     Int J Cardiol. 2024;416:132510.
     

     >> Share

     
     
254. LIU Y, Huang M, Dai W
     Letter to the editor: Drug-coated balloon angioplasty versus drug-eluting stent implantation in ACS patients with different angiographic patterns of in-stent restenosis.
     Int J Cardiol. 2024;416:132501.
     

     >> Share

     
     
255. MONARES-ZEPEDA E, Barrera-Hoffmann C, Cueto-Robledo G, Navarro-Vergara DI, et al
     Mechanical power in cardiogenic shock.
     Int J Cardiol. 2024;416:132499.
     

     >> Share

     
     
256. WU Y, Lin Y, Liu B, Ma J, et al
     Shexiang Tongxin dropping pill ameliorates microvascular obstruction via downregulating ALOX12 after myocardial ischemia-reperfusion.
     Int J Cardiol. 2024;416:132481.
     

     >> Share

     
     
257. ZHANG W, Zhang W, Deng Y, Gu N, et al
     Non-target lesion progression: Unveiling critical predictors and outcomes in patients with in-stent restenosis.
     Int J Cardiol. 2024;416:132451.
     

     >> Share

     
     November 2024
258. FEZZI S, Pesarini G, Flaim M, Ding D, et al
     Influence of physiological patterns of coronary disease on fractional flow reserve and instantaneous wave-free ratio changes in patients undergoing TAVI.
     Int J Cardiol. 2024 Nov 25:132761. doi: 10.1016/j.ijcard.2024.132761.
     

     >> Share

     
     
259. ALEKSOVA A, Fluca AL, Janjusevic M, Padoan L, et al
     Differences between MINOCA and type 2 myocardial infarction: An ITALIAN observational study.
     Int J Cardiol. 2024 Nov 24:132745. doi: 10.1016/j.ijcard.2024.132745.
     

     >> Share

     
     
260. ZHU Q, Li X
     Reply to "Can IGFBP5 levels predict major adverse cardiac events in hyperglycemic AMI patients?".
     Int J Cardiol. 2024;415:132471.
     

     >> Share

     
     
261. VINK CEM, de Jong EAM, Woudstra J, Molenaar M, et al
     The role of myocardial blood volume in the pathophysiology of angina with non-obstructed coronary arteries: The MICORDIS study.
     Int J Cardiol. 2024;415:132479.
     

     >> Share

     
     
262. IWANCZYK S, Lazar FL, Onea HL, Pesenti N, et al
     Sirolimus-coated balloon versus drug-eluting stent for complex coronary lesions. A propensity matched comparison.
     Int J Cardiol. 2024;415:132436.
     

     >> Share

     
     
263. LECHNER I, Reindl M, Metzler B, Reinstadler SJ, et al
     Temporal trends in ACS outcomes: Balancing technological advances with patient complexity.
     Int J Cardiol. 2024;415:132442.
     

     >> Share

     
     
264. XIE H, Qiu M, Li X, Xiao Y, et al
     Drug-coated balloon angioplasty versus drug-eluting stent implantation in ACS patients with different angiographic patterns of in-stent restenosis.
     Int J Cardiol. 2024;415:132450.
     

     >> Share

     
     
265. KINI AS, Garcia H, Springer B, Vengrenyuk A, et al
     A mobile application for STEMI care optimization: Pilot implementation project report.
     Int J Cardiol. 2024;415:132447.
     

     >> Share

     
     
266. LIANG ES, Liu X
     Slamf8: A potential therapeutic target for cardiac ischemia/reperfusion injury.
     Int J Cardiol. 2024;415:132446.
     

     >> Share

     
     
267. ONG P, Seitz A
     Precision medicine in the treatment of STEMI patients - it's time for coronary physiology!
     Int J Cardiol. 2024;415:132429.
     

     >> Share

     
     
268. DI VITO L, Di Giusto F, Mazzotta S, Scalone G, et al
     Management of vulnerable patient phenotypes and acute coronary syndrome mechanisms.
     Int J Cardiol. 2024;415:132365.
     

     >> Share

     
     
269. PETERS EJ, Ten Berg S, Bogerd M, Engstrom AE, et al
     Sex disparities in myocardial infarction related cardiogenic shock.
     Int J Cardiol. 2024;420:132730.
     

     >> Share

     
     
270. HOOKANA I, Junttila J
     Reply to the letter "Age-related trends of ischemic sudden cardiac death in women".
     Int J Cardiol. 2024;414:132439.
     

     >> Share

     
     
271. SHARMA R, Aggarwal G, Kumar A, Thakur AK, et al
     Effect of loss-of-function CYP2C19 variants on clinical outcomes in coronary artery disease patients treated with clopidogrel: A systematic meta-analysis approach.
     Int J Cardiol. 2024;414:132418.
     

     >> Share

     
     
272. XU W
     Ultrasonic flow ratio to diagnosis the functional significance of coronary stenosis undergoing percutaneous coronary intervention.
     Int J Cardiol. 2024;414:132427.
     

     >> Share

     
     
273. KOOP Y, Nathoe H, Bots M, Grobbee DE, et al
     Octopus follow-up: 20 year prognosis in patients randomized to on-pump CABG, off-pump CABG or PCI.
     Int J Cardiol. 2024;414:132426.
     

     >> Share

     
     
274. NAKAMURA R, Shiono Y, Honda K, Kunimoto H, et al
     Risk factors for unsuccessful restoration of coronary flow reserve after coronary bypass surgery.
     Int J Cardiol. 2024;414:132419.
     

     >> Share

     
     
275. SAMI SZ
     Letter to the Editor: The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome.
     Int J Cardiol. 2024;414:132406.
     

     >> Share

     
     
276. EL-NAGGAR HM, Soliman MG, Demitry SR, Ahmed TAN, et al
     Vitamin-K antagonist versus dual antiplatelet therapy in management of isolated and non-obstructive atherosclerotic coronary artery ectasia.
     Int J Cardiol. 2024;414:132412.
     

     >> Share

     
     
277. REGIS SC, Del Castillo-Rix D, Duque JC, Colombo R, et al
     Evaluating the incidence and risk factors for developing acute tubular necrosis after percutaneous coronary intervention in the management of coronary artery dissection.
     Int J Cardiol. 2024;414:132403.
     

     >> Share

     
     
278. JIANG Y, Wei ZY, Wu YJ, Dou KF, et al
     The impacts of percutaneous coronary intervention to treat chronic total occlusion of right coronary artery on the 5-year prognosis: A single-centered retrospective study.
     Int J Cardiol. 2024;414:132384.
     

     >> Share

     
     October 2024
279. WEIGHT N, Singh S, Moledina S, Mamas MA, et al
     The processes of care and long-term mortality of acute myocardial infarction with cardiogenic shock survivors: A nationwide cohort study.
     Int J Cardiol. 2024 Oct 21:132669. doi: 10.1016/j.ijcard.2024.132669.
     

     >> Share

     
     
280. GRECO A, Scalia L, Laudani C, Spagnolo M, et al
     Downstream cangrelor versus upstream ticagrelor in patients with ST-segment elevation myocardial infarction: A propensity score-matched analysis.
     Int J Cardiol. 2024;418:132660.
     

     >> Share

     
     
281. FANG Y, Huang S, Zhang H, Yu M, et al
     The association between fibrinogen-to-albumin ratio and adverse prognosis in patients with myocardial infarction with non-obstructive coronary arteries.
     Int J Cardiol. 2024 Oct 17:132665. doi: 10.1016/j.ijcard.2024.132665.
     

     >> Share

     
     
282. BAN T, Chang Y, Yu R
     Can IGFBP5 levels predict major adverse cardiac events in hyperglycemic AMI patients?
     Int J Cardiol. 2024;413:132407.
     

     >> Share

     
     
283. LORCA R, Aparicio A, Gutierrez L, Alvarez-Velasco R, et al
     PCSK9 gene variations in the clinical setting of premature cardiovascular disease: A critical appraisal.
     Int J Cardiol. 2024;413:132402.
     

     >> Share

     
     
284. BIANCHINI E, Basile M, Bianchini F, Zito A, et al
     Multivessel revascularization in non-ST segment elevation acute coronary syndromes: A systematic review and meta-analysis of 182,798 patients.
     Int J Cardiol. 2024;413:132392.
     

     >> Share

     
     
285. MICHAUD K, van der Wal AC
     Age and sex disparities in myocardial ischemia-related deaths at autopsy.
     Int J Cardiol. 2024;413:132362.
     

     >> Share

     
     
286. IWUAGWU M, Olapoju O, Abolaji M
     Age- related trends of ischemic sudden cardiac death in women.
     Int J Cardiol. 2024;413:132349.
     

     >> Share

     
     
287. CHUNTA A, Miller RJH
     Uncovering STEMI patient phenotypes using unsupervised machine learning.
     Int J Cardiol. 2024;413:132346.
     

     >> Share

     
     
288. OLMO RF, Cortez G, Toro MM, Sandin M, et al
     A machine learning algorithm for the identification elevated Lp(a) in patients with, or high-risk of having, coronary heart disease.
     Int J Cardiol. 2024 Oct 2:132612. doi: 10.1016/j.ijcard.2024.132612.
     

     >> Share

     
     
289. DENG C, Liu Z, Li C, Xu G, et al
     Predictive models for cholesterol crystals and plaque vulnerability in acute myocardial infarction: Insights from an optical coherence tomography study.
     Int J Cardiol. 2024 Oct 2:132610. doi: 10.1016/j.ijcard.2024.132610.
     

     >> Share

     
     
290. GUGLIELMO M, Fusini L, Baessato F, Baggiano A, et al
     PROGnostic RolE of strain measurements in stress cardiac MRI in predicting major adverse cardiac events.
     Int J Cardiol. 2024;412:132337.
     

     >> Share

     
     
291. AYAYO SA, Kontopantelis E, Martin GP, Zghebi SS, et al
     Temporal trends of in-hospital mortality and its determinants following percutaneous coronary intervention in patients with acute coronary syndrome in England and Wales: A population-based study between 2006 and 2021.
     Int J Cardiol. 2024;412:132334.
     

     >> Share

     
     
292. WU Z, Liu T, Yang Z, Li Y, et al
     Exploring the path of inflammatory markers as clinical prognostic biomarkers in older NSTEACS patients.
     Int J Cardiol. 2024;412:132309.
     

     >> Share

     
     
293. WANG YP, Xu XD, Xu X, Zhu L, et al
     Aucubin protects against myocardial ischemia-reperfusion injury via activation of the AKT/STAT3 pathway.
     Int J Cardiol. 2024;412:132311.
     

     >> Share

     
     
294. ZHANG ZJ
     The need to account for concurrent thrombus aspiration when investigating the adverse impact of post-dilation during percutaneous coronary intervention.
     Int J Cardiol. 2024;412:132296.
     

     >> Share

     
     
295. KUMAR M, Kumar N, Upreti P, Zaka Haider M, et al
     Drug-eluting stent vs. Balloon angioplasty in patients with in-stent restenosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
     Int J Cardiol. 2024;412:132269.
     

     >> Share

     
     September 2024
296. DE LUCA L, Maggioni AP, Cavallini C, Leonardi S, et al
     Clinical profile and management of patients with acute myocardial infarction admitted to cardiac care units: The EYESHOT-2 registry.
     Int J Cardiol. 2024;418:132601.
     

     >> Share

     
     
297. ZHANG Q, Zhu T, Mingqiang AO, Chen J, et al
     Correlation between serum levels of circ_0001879 and circ_0004104, coronary microcirculation disorders and prognosis after percutaneous coronary intervention (PCI) in patients with stable coronary heart disease.
     Int J Cardiol. 2024 Sep 18:132559. doi: 10.1016/j.ijcard.2024.132559.
     

     >> Share

     
     
298. PROVENZALE G, Barbieri L, Tumminello G, Carugo S, et al
     Exercise response in post-acute coronary syndrome patients survived to COVID-19 infection.
     Int J Cardiol. 2024;411:132285.
     

     >> Share

     
     
299. TILLER C, Reindl M, Lechner I, Reinstadler SJ, et al
     Circulating progenitor cells: A promising biomarker for coronary collateral formation in CTO?
     Int J Cardiol. 2024;411:132267.
     

     >> Share

     
     
300. GADAGER BB, Tang LH, Doherty P, Svendsen ML, et al
     Are cardiac rehabilitation pathways influenced by diabetes: A cohort study.
     Int J Cardiol. 2024;411:132275.
     

     >> Share

     
     
301. DI FRANCO A
     Navigating complexity among surgical myocardial revascularization strategies: Endoscopic coronary artery bypass gains support.
     Int J Cardiol. 2024;410:132240.
     

     >> Share

     
     
302. ABU ARAB T, Sedhom R, Gomaa Y, El Etriby A, et al
     Intracoronary adenosine compared with adrenaline and verapamil in the treatment of no-reflow phenomenon following primary PCI in STEMI patients.
     Int J Cardiol. 2024;410:132228.
     

     >> Share

     
     
303. BAHARVAND F, Habibi Roudkenar M, Pourmohammadi-Bejarpasi Z, Najafi-Ghalehlou N, et al
     Safety and efficacy of platelet-derived mitochondrial transplantation in ischaemic heart disease.
     Int J Cardiol. 2024;410:132227.
     

     >> Share

     
     
304. HOOKANA I, Eskuri MAE, Holmstrom L, Vahatalo J, et al
     Age-related trends of ischemic sudden cardiac death in women.
     Int J Cardiol. 2024;410:132238.
     

     >> Share

     
     
305. ABOAL J, Ramos R, Martin C, Loma-Osorio P, et al
     Evaluation of the ODISEA APP for improving a STEMI regional network.
     Int J Cardiol. 2024;410:132217.
     

     >> Share

     
     
306. ABDELBASIT MS
     How often is emergency coronary artery bypass grafting required during chronic total occlusion coronary intervention?
     Int J Cardiol. 2024;410:132215.
     

     >> Share

     
     
307. TIERNEY M, Norman S, Al Ahmad J, Hansen T, et al
     A 10-year review of presentation, management and outcomes of STEMI in a high-volume regional tertiary Australian centre.
     Int J Cardiol. 2024;410:132224.
     

     >> Share

     
     
308. REGIS SC, Del Castillo-Rix D, Colombo R
     Patterns of coronary artery disease trends in patients with nephrotic syndrome: A national inpatient study.
     Int J Cardiol. 2024;410:132200.
     

     >> Share

     
     August 2024
309. YAN M, Fu H, Zhang X, Xu K, et al
     More attention needs to focus on the diabetic cardiomyopathy without coronary artery disease.
     Int J Cardiol. 2024;409:132194.
     

     >> Share

     
     
310. MENDEL B
     Gender differences in the diagnostic efficacy of coronary CTA: Overutilization of coronary CTA in pre- and perimenopausal females? An editorial comment.
     Int J Cardiol. 2024;409:132193.
     

     >> Share

     
     
311. GOLD DA, Sandesara PB, Jain V, Gold ME, et al
     N terminal pro-brain natriuretic peptide level and benefits of chronic total occlusion revascularization.
     Int J Cardiol. 2024;409:132196.
     

     >> Share

     
     
312. HOSSEINI K, Behnoush AH, Khalaji A, Etemadi A, et al
     Machine learning prediction of one-year mortality after percutaneous coronary intervention in acute coronary syndrome patients.
     Int J Cardiol. 2024;409:132191.
     

     >> Share

     
     
313. BRUNO F, De Filippo O, D'Ascenzo F
     Reply to "Sex disparities for clinical outcomes after percutaneous coronary intervention for acute coronary syndrome" by Sterpetti et al.
     Int J Cardiol. 2024;409:132186.
     

     >> Share

     
     
314. ROMANOV A, Nikitin N
     Epicardial adipose tissue for atrial arrhythmias prediction in coronary artery disease. Are we close to the gold marker?
     Int J Cardiol. 2024;409:132176.
     

     >> Share

     
     
315. FERNANDES-SILVA MM, Conti-Pelanda JD, Vosgerau LM, Cunha GSP, et al
     Temporal trends in the contribution of modifiable cardiovascular risk factors to cardiovascular and all-cause mortality in patients undergoing myocardial perfusion imaging in a large city in Brazil.
     Int J Cardiol. 2024;409:132178.
     

     >> Share

     
     
316. FEUCHTNER GM, Lacaita PG, Barbieri F, Deeg J, et al
     Gender differences in the diagnostic efficacy of coronary CTA: Overutilization of coronary CTA in pre- and perimenopausal females?
     Int J Cardiol. 2024;409:132181.
     

     >> Share

     
     
317. SAMPON F, Ter Woorst J, Dekker L, Akca F, et al
     Thoracoscopic-assisted, minimally invasive versus off-pump bypass grafting for single vessel coronary artery disease - A propensity matched analysis.
     Int J Cardiol. 2024;409:132175.
     

     >> Share

     
     
318. FRACASSI F, Animati FM, Cappannoli L, Burzotta F, et al
     Thin-cap fibroatheroma: the trigger of acute coronary syndromes. Pathophysiological and prognostic importance of in-vivo detection.
     Int J Cardiol. 2024;409:132157.
     

     >> Share

     
     
319. SI X, Hou C, Wang H, Yan W, et al
     Comparison of six Z-score formulas based on echocardiography for coronary artery lesions in Kawasaki disease.
     Int J Cardiol. 2024;409:132102.
     

     >> Share

     
     
320. YI L, Quan W, Zhang M, Zhu T, et al
     Potential of (68)Ga-FAPI-04 PET/MR to predict worsening renal function after acute ST-elevation myocardial infarction.
     Int J Cardiol. 2024 Aug 2:132425. doi: 10.1016/j.ijcard.2024.132425.
     

     >> Share

     
     
321. GHOBRIAL M, Bawamia B, Cartlidge T, Purcell I, et al
     The role of gender in resting full-cycle ratio (RFR) guided coronary revascularization.
     Int J Cardiol. 2024;408:132159.
     

     >> Share

     
     
322. HONGQUAN L, Nina C, Xia Y, Lujiang Z, et al
     BECN1 regulates FADD/RIPK1/Caspase-8 complex formation via RIPK1 ubiquitination by downregulating OTUD1 in MI/R induced myocyte apoptosis.
     Int J Cardiol. 2024;408:132158.
     

     >> Share

     
     
323. LANDI A, Heg D, Frigoli E, Routledge H, et al
     Negative selection bias for women inclusion in a clinical trial.
     Int J Cardiol. 2024;408:132138.
     

     >> Share

     
     
324. ALGHAMMASS M, Arora S
     Navigating complex waters: Revascularization strategies and outcomes in post-CABG patients.
     Int J Cardiol. 2024;408:132120.
     

     >> Share

     
     July 2024
325. DE FERRARI T, Pistelli L, Franzino M, Molinero AE, et al
     MI2AMI-CS: A meta-analysis comparing Impella and IABP outcomes in acute myocardial infarction-related cardiogenic shock.
     Int J Cardiol. 2024 Jul 31:132411. doi: 10.1016/j.ijcard.2024.132411.
     

     >> Share

     
     
326. TSENG CH
     Metformin-associated lactic acidosis and mortality in type 2 diabetes patients hospitalized with heart failure and/or acute coronary syndrome: A neglected clinical scenario and the potential role of insulin.
     Int J Cardiol. 2024 Jul 30:132400. doi: 10.1016/j.ijcard.2024.132400.
     

     >> Share

     
     
327. LI YY, Chen HR, Yang Y, Pan YJ, et al
     Murine exosomal miR-30a aggravates cardiac function after acute myocardial infarction via regulating cell fate of cardiomyocytes and cardiac resident macrophages.
     Int J Cardiol. 2024 Jul 27:132395. doi: 10.1016/j.ijcard.2024.132395.
     

     >> Share

     
     
328. NAJAFI-GHALEHLOU N, Baharvand F, Pourmohammadi-Bejarpasi Z, Roushandeh AM, et al
     The importance of platelet-derived mitochondrial transplantation in ischemic heart disease: A clinical study.
     Int J Cardiol. 2024;413:132408.
     

     >> Share

     
     
329. DENG L, Xia Q, Zhang L
     Commentary on "Automated control of Impella maintains optimal left ventricular unloading during periods of unstable hemodynamics and prevents myocardial damage in acute myocardial infarction".
     Int J Cardiol. 2024;413:132383.
     

     >> Share

     
     
330. D'ERRIGO P, De Luca L, Rosato S, Giordani B, et al
     Prognostic role of coronary angiography and revascularization in patients firstly admitted for heart failure in Italy.
     Int J Cardiol. 2024 Jul 23:132369. doi: 10.1016/j.ijcard.2024.132369.
     

     >> Share

     
     
331. GOLD DA, Sandesara PB, Kindya B, Gold ME, et al
     Circulating Progenitor Cells and Coronary Collaterals in Chronic Total Occlusion.
     Int J Cardiol. 2024;407:132104.
     

     >> Share

     
     
332. CANDREVA A, Buongiorno AL, Matter MA, Rizzini ML, et al
     Impact of endothelial shear stress on coronary atherosclerotic plaque progression and composition: A meta-analysis and systematic review.
     Int J Cardiol. 2024;407:132061.
     

     >> Share

     
     
333. GROEN RA, Barbero FL, Fischer SE, van Dijkman PRM, et al
     Coronary artery calcium assessment on non-gated chest CT to optimize pre-operative cardiac screening in liver transplantation.
     Int J Cardiol. 2024;407:132015.
     

     >> Share

     
     
334. SMITH SW, Meyers HP
     ST Elevation is a poor surrogate for acute coronary occlusion. Let's Replace STEMI with Occlusion MI (OMI)!!
     Int J Cardiol. 2024;407:131980.
     

     >> Share

     
     
335. KOH SJQ, Jiang Y, Lau YH, Yip WLJ, et al
     Optimal door-to-balloon time for primary percutaneous coronary intervention for ST-elevation myocardial infarction.
     Int J Cardiol. 2024;413:132345.
     

     >> Share

     
     
336. ZHANG L, Liu Z, Zeng J, Wu M, et al
     Long-term effects of air quality on hospital readmission for heart failure in patients with acute myocardial infarction.
     Int J Cardiol. 2024 Jul 6:132344. doi: 10.1016/j.ijcard.2024.132344.
     

     >> Share

     
     
337. LIU S, Qian F, Lu Q, Deng Y, et al
     Association of life's essential 8 with risk of recurrent cardiovascular events among patients with coronary heart disease.
     Int J Cardiol. 2024;412:132318.
     

     >> Share

     
     
338. BASEM M, Bonnesen K, Schmidt M
     Potential of the Danish Comorbidity Index for Acute Myocardial Infarction to discriminate mortality in patients with infective endocarditis.
     Int J Cardiol. 2024 Jul 2:132328. doi: 10.1016/j.ijcard.2024.132328.
     

     >> Share

     
     
339. SIGLE M, Faller W, Heurich D, Zdanyte M, et al
     Machine learning predicts emergency physician specialties from treatment strategies for patients suspected of myocardial infarction.
     Int J Cardiol. 2024 Jul 2:132332. doi: 10.1016/j.ijcard.2024.132332.
     

     >> Share

     
     
340. FUJINO M, Aikawa H, Nakao K, Takagi K, et al
     Comparison of embolic risk in left ventricular thrombus between nonischemic and ischemic cardiomyopathy: A nationwide database analysis.
     Int J Cardiol. 2024 Jul 2:132329. doi: 10.1016/j.ijcard.2024.132329.
     

     >> Share

     
     
341. LEE YJ, Park G, Lee SG, Cho YK, et al
     Predictive value of plaque characteristics for identification of lesions causing ischemia.
     Int J Cardiol. 2024;406:132097.
     

     >> Share

     
     
342. AKSIT E, Kucuk U, Kirilmaz B
     The increasing importance of lipid lowering therapies as a part of the 'first medical contact' in patients with acute coronary syndrome.
     Int J Cardiol. 2024;406:132095.
     

     >> Share

     
     
343. GASECKA A, Blazejowska E, Pluta K, Gajewska M, et al
     Ticagrelor downregulates the expression of proatherogenic and proinflammatory miR125-b compared to clopidogrel: A randomized, controlled trial.
     Int J Cardiol. 2024;406:132073.
     

     >> Share

     
     
344. MOMMERSTEEG PMC, Lodder P, Aarnoudse W, Magro M, et al
     Psychosocial distress and health status as risk factors for ten-year major adverse cardiac events and mortality in patients with non-obstructive coronary artery disease.
     Int J Cardiol. 2024;406:132062.
     

     >> Share

     
     
345. TILLMANNS J, Weiglein JM, Neuser J, Fraccarollo D, et al
     Circulating soluble fibroblast activation protein (FAP) levels are independent of cardiac and extra-cardiac FAP expression determined by targeted molecular imaging in patients with myocardial FAP activation.
     Int J Cardiol. 2024;406:132044.
     

     >> Share

     
     
346. REN Y, Chen L, Liu J, Wu Y, et al
     Correlation of epicardial adipose tissue and inflammatory indices in patients with STEMI and implications for atrial arrhythmias.
     Int J Cardiol. 2024;406:132016.
     

     >> Share

     
     
347. CHADHA RM
     CT coronary angiography: Is it the new standard in coronary assessment for liver transplant candidates?
     Int J Cardiol. 2024;406:131999.
     

     >> Share

     
     
348. YAZDANPANAH M, Yazdanpanah N, Chardoli M, Dehghan A, et al
     Role of interleukin 6 signaling pathway in the anti-inflammatory effects of statins on coronary artery disease: Evidence from Mendelian randomization analysis.
     Int J Cardiol. 2024;406:131964.
     

     >> Share

     
     June 2024
349. CORDERO A, Oterino A
     Individualization of prasugrel dose for patients with acute myocardial infarction.
     Int J Cardiol. 2024 Jun 29:132313. doi: 10.1016/j.ijcard.2024.132313.
     

     >> Share

     
     
350. KUBAT GB
     The importance of platelet-derived mitochondrial transplantation in ischemic heart disease: A clinical study.
     Int J Cardiol. 2024;412:132312.
     

     >> Share

     
     
351. LIU XH, Zhang L
     Role of anakinra in patients with ST-elevation myocardial infarction.
     Int J Cardiol. 2024 Jun 25:132297. doi: 10.1016/j.ijcard.2024.132297.
     

     >> Share

     
     
352. JIN Y, Shen L, Ye R, Zhou M, et al
     Development and validation of a novel score for predicting perioperative major adverse cardiovascular events in patients with stable coronary artery disease undergoing noncardiac surgery.
     Int J Cardiol. 2024;405:131982.
     

     >> Share

     
     
353. BEERKENS FJ, Kucuk IT, van Veelen A, de Lind van Wijngaarden RAF, et al
     Native coronary artery or bypass graft percutaneous coronary intervention in patients after previous coronary artery bypass surgery: A large nationwide analysis from the Netherlands Heart Registration.
     Int J Cardiol. 2024;405:131974.
     

     >> Share

     
     
354. LI C, Deng C, Shi B, Zhao R, et al
     Thin-cap fibroatheroma in acute coronary syndrome: Implication for intravascular imaging assessment.
     Int J Cardiol. 2024;405:131965.
     

     >> Share

     
     
355. IN KIM Y, Roh JH, Kweon J, Kwon H, et al
     Artificial intelligence-based quantitative coronary angiography of major vessels using deep-learning.
     Int J Cardiol. 2024;405:131945.
     

     >> Share

     
     
356. SCHINDLER TH, Sadhu J
     Moving towards PET determined coronary flow capacity in outcome prediction after coronary revascularization?
     Int J Cardiol. 2024;405:131921.
     

     >> Share

     
     
357. MUTLU D, Rempakos A, Alexandrou M, Al-Ogaili A, et al
     Emergency coronary artery bypass surgery after chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
     Int J Cardiol. 2024;405:131931.
     

     >> Share

     
     
358. TOFTHOLM MH, Hojstrup S, Talleruphuus U, Marner L, et al
     82-rubidium positron emission tomography determined myocardial flow reserve and outcomes following cardiac revascularisation - A multicentre registry study.
     Int J Cardiol. 2024;405:131865.
     

     >> Share

     
     
359. MATETIC A, Kyriacou T, Mamas MA
     Machine-learning clustering analysis identifies novel phenogroups in patients with ST-elevation acute myocardial infarction.
     Int J Cardiol. 2024 Jun 14:132272. doi: 10.1016/j.ijcard.2024.132272.
     

     >> Share

     
     
360. ZHU Q, Cheang I, Guo Q, Lu X, et al
     Serum IGFBP5 as a predictor of major adverse cardiac events in patients with acute myocardial infarction.
     Int J Cardiol. 2024 Jun 14:132268. doi: 10.1016/j.ijcard.2024.132268.
     

     >> Share

     
     
361. CHEN Y, Zhang N, Gao Y, Zhou Z, et al
     A coronary CT angiography-derived myocardial radiomics model for predicting adverse outcomes in chronic myocardial infarction.
     Int J Cardiol. 2024 Jun 14:132265. doi: 10.1016/j.ijcard.2024.132265.
     

     >> Share

     
     
362. WANG L, Travieso A, van der Hoeven N, Lombardi M, et al
     Angiography-versus wire-based microvascular resistance index to detect coronary microvascular obstruction associated with ST-segment elevation myocardial infarction.
     Int J Cardiol. 2024 Jun 10:132256. doi: 10.1016/j.ijcard.2024.132256.
     

     >> Share

     
     
363. BANJAR S, Alharbi S, Omer I, Al Zaid N, et al
     Effect of sodium-glucose co-transporter 2 inhibitors (SGLT2i) on N-terminal pro-B-type natriuretic peptide (NT-proBNP) level and structural changes following myocardial infarction: A systematic review and meta-analysis.
     Int J Cardiol. 2024;410:132239.
     

     >> Share

     
     
364. NISHIKAWA T, Kamada K, Morita H, Matsushita H, et al
     Automated control of Impella maintains optimal left ventricular unloading during periods of unstable hemodynamics and prevents myocardial damage in acute myocardial infarction.
     Int J Cardiol. 2024;410:132244.
     

     >> Share

     
     
365. MCCHORD J, Ong P
     Advancing precision medicine in INOCA research: The INOCA-IT registry.
     Int J Cardiol. 2024;404:131975.
     

     >> Share

     
     
366. SHIBA M, Kato T, Seko Y, Minamino-Muta E, et al
     Cobalt protoporphyrin promotes heme oxygenase 1 expression and ameliorates cardiac dysfunction in long-term fasting mice.
     Int J Cardiol. 2024;404:131972.
     

     >> Share

     
     
367. STERPETTI AV, Gabriele R, Di Marzo L
     Sex disparities for clinical outcomes after percutaneous coronary intervention for acute coronary syndrome.
     Int J Cardiol. 2024;404:131937.
     

     >> Share

     
     
368. BACIGALUPI E, Pelliccia F, Zimarino M
     Diabetes mellitus and in-stent restenosis: A direct link or something more?
     Int J Cardiol. 2024;404:131922.
     

     >> Share

     
     
369. GOLINO M, Harding D, Del Buono MG, Fanti S, et al
     Innate and adaptive immunity in acute myocarditis.
     Int J Cardiol. 2024;404:131901.
     

     >> Share

     
     May 2024
370. HONDA S, Lee S, Cho KH, Takegami M, et al
     Clinical outcomes of adjusted-dose versus standard-dose prasugrel in East Asian patients with acute myocardial infarction.
     Int J Cardiol. 2024 May 30:132197. doi: 10.1016/j.ijcard.2024.132197.
     

     >> Share

     
     
371. SUN L, Xu C, Zhang Z, Tang L, et al
     Physical activity lowers all-cause and cardio-cerebrovascular mortality in adults with coronary heart disease.
     Int J Cardiol. 2024;410:132225.
     

     >> Share

     
     
372. REA F
     Progress in cardiovascular mortality: Latest data on mortality from ischemic heart disease.
     Int J Cardiol. 2024;409:132192.
     

     >> Share

     
     
373. CHEN G, Westra J, Yang X, Zhang Y, et al
     A simple Angio-based coronary flow assessment of culprit vessels in primary percutaneous coronary intervention is associated with long-term prognosis after ST-segment-elevation myocardial infarction.
     Int J Cardiol. 2024 May 21:132199. doi: 10.1016/j.ijcard.2024.132199.
     

     >> Share

     
     
374. WANG SR, Huang KC, Lin TT, Chuang SL, et al
     The effect of antiarrhythmic medications on the risk of cardiovascular outcomes in patients with atrial fibrillation and coronary artery disease.
     Int J Cardiol. 2024 May 21:132198. doi: 10.1016/j.ijcard.2024.132198.
     

     >> Share

     
     
375. UKITA K, Egami Y, Yano M, Nishino M, et al
     Reply to "Evaluation on mortality predictors after emergent percutaneous coronary intervention in acute myocardial infarction with ventricular arrhythmias: Details not to be ignored?".
     Int J Cardiol. 2024;409:132187.
     

     >> Share

     
     
376. YAO L, Hao K, Liu T, Jiang J, et al
     The miR-26b/CTGF axis: A promising therapeutic mechanism for managing myocardial fibrosis post myocardial infarction.
     Int J Cardiol. 2024;409:132185.
     

     >> Share

     
     
377. DIRJAYANTO VJ, Martin-Ruiz C, Pompei G, Rubino F, et al
     The association of inflammatory biomarkers and long-term clinical outcomes in older adults with non-ST elevation acute coronary syndrome.
     Int J Cardiol. 2024;409:132177.
     

     >> Share

     
     
378. SAMPAIO RODRIGUES T, Narendren A, Cailes B, Lim RP, et al
     Enhancing pre-transplant cardiac assessment: Validation and utility of the CAD-LT score with CCTA in liver transplant candidates.
     Int J Cardiol. 2024;403:131895.
     

     >> Share

     
     
379. XU P, Cao Y, Zhang S, Liu X, et al
     The predictive value of serum Dickkopf-1, Dickkopf-3 level to coronary artery disease and acute coronary syndrome.
     Int J Cardiol. 2024;403:131887.
     

     >> Share

     
     
380. DOUGHTY A, Keane G, Wadley AJ, Mahoney B, et al
     Plasma concentrations of thioredoxin, thioredoxin reductase and peroxiredoxin-4 can identify high risk patients and predict outcome in patients with acute coronary syndrome: A clinical observation.
     Int J Cardiol. 2024;403:131888.
     

     >> Share

     
     
381. SAARINEN SL, Borregaard B, Ekholm O, Christensen AV, et al
     Self-reported mental and physical health is associated with not returning to work in patients with ischemic heart disease.
     Int J Cardiol. 2024 May 15:132180. doi: 10.1016/j.ijcard.2024.132180.
     

     >> Share

     
     
382. LOPEZ-PALOP R, Carrillo P, Lozano I
     Transient new-onset atrial fibrillaation during acute coronary syndrome: Transient arrhythmia, transient risk?
     Int J Cardiol. 2024 May 14:132163. doi: 10.1016/j.ijcard.2024.132163.
     

     >> Share

     
     
383. DE ALENCAR NETO JN, Scheffer MK, Correia BP, Franchini KG, et al
     Systematic review and meta-analysis of diagnostic test accuracy of ST-segment elevation for acute coronary occlusion.
     Int J Cardiol. 2024;402:131889.
     

     >> Share

     
     
384. OLSEN FJ, Smiseth OA, Biering-Sorensen T
     Improving post-MI risk stratification with pressure-strain loops: Work in progress.
     Int J Cardiol. 2024;402:131866.
     

     >> Share

     
     
385. DI VITO L, Di Giusto F, Grossi P
     Non-culprit plaque progression: What do we know?
     Int J Cardiol. 2024;402:131881.
     

     >> Share

     
     
386. GHIZZONI G, Leone AM, di Serafino L, Galante D, et al
     "The INOCA-IT: Rationale and design of a multicenter registry investigating ischemia in patients with non-obstructive coronary artery (INOCA) disease in Italy".
     Int J Cardiol. 2024;402:131859.
     

     >> Share

     
     
387. AL-YAFEAI Z, Sondhi M, Vadlamudi K, Vyas R, et al
     Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS).
     Int J Cardiol. 2024;402:131819.
     

     >> Share

     
     April 2024
388. JHAND AS, Abusnina W, Tak HJ, Ahmed A, et al
     Impact of anemia on outcomes and resource utilization in patients with myocardial infarction: A national database analysis.
     Int J Cardiol. 2024 Apr 30:132111. doi: 10.1016/j.ijcard.2024.132111.
     

     >> Share

     
     
389. MIURA H, Koseki M, Ide S, Asaumi Y, et al
     Stronger positive correlation of the left ventricular mass index and extracellular volume fraction with diastolic function in diabetic patients without myocardial infarction.
     Int J Cardiol. 2024 Apr 23:132099. doi: 10.1016/j.ijcard.2024.132099.
     

     >> Share

     
     
390. AL A, Babayigit E, Gorenek B
     Evaluation on mortality predictors after emergent percutaneous coronary intervention in acute myocardial infarction with ventricular arrhythmias: Details not to be ignored?
     Int J Cardiol. 2024;406:132079.
     

     >> Share

     
     
391. GIRERD N
     The underappreciated value of resting heart rate in post-myocardial infarction follow-up.
     Int J Cardiol. 2024 Apr 19:132059. doi: 10.1016/j.ijcard.2024.132059.
     

     >> Share

     
     
392. ANDO G, Lombardo L, Alagna G, Micari A, et al
     Monotherapy with P2Y(12)-inhibitors after dual antiplatelet therapy: Filling gaps in evidence.
     Int J Cardiol. 2024;401:131893.
     

     >> Share

     
     
393. BRUNO F, de Filippo O, Sardone A, Capranzano P, et al
     Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study.
     Int J Cardiol. 2024;401:131861.
     

     >> Share

     
     
394. HAN D, Hyun MC, Miller RJH, Gransar H, et al
     10-year experience of utilizing a stress-first SPECT myocardial perfusion imaging.
     Int J Cardiol. 2024;401:131863.
     

     >> Share

     
     
395. TANNER R, Farhan S, Giustino G, Sartori S, et al
     Impact of diabetes mellitus on clinical outcomes after first episode in-stent restenosis PCI: Results from a large registry.
     Int J Cardiol. 2024;401:131856.
     

     >> Share

     
     
396. XIA B, Lu Y, Liang J, Li F, et al
     Association of GAL-8 promoter methylation levels with coronary plaque inflammation.
     Int J Cardiol. 2024;401:131782.
     

     >> Share

     
     
397. RIEHLE C, Sieweke JT, Udesen NLJ, Helgestad OKL, et al
     Circulating biomarkers of the CS4P and CLIP scores are not altered in a pig model of acute cardiogenic shock and additional short-term circulatory support.
     Int J Cardiol. 2024;401:131699.
     

     >> Share

     
     
398. WOLF S, Schievano E, Amidei CB, Kucher N, et al
     Mortality trend of ischemic heart disease (2008-2022): A retrospective analysis of epidemiological data.
     Int J Cardiol. 2024 Apr 12:132042. doi: 10.1016/j.ijcard.2024.132042.
     

     >> Share

     
     
399. YANG J, Zhao Y, Wang J, Ma L, et al
     Current status of emergency medical service use in ST-segment elevation myocardial infarction in China: Findings from China Acute Myocardial Infarction (CAMI) Registry.
     Int J Cardiol. 2024 Apr 11:132040. doi: 10.1016/j.ijcard.2024.132040.
     

     >> Share

     
     
400. JONG CB, Lu TS, Chen JW
     Reply to comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
     Int J Cardiol. 2024 Apr 10:132031. doi: 10.1016/j.ijcard.2024.132031.
     

     >> Share

     
     
401. UELAND T, Butt N, Lekva T, Orn S, et al
     High dose statin treatment reduces circulating Dickkopf-1 following acute myocardial infarction.
     Int J Cardiol. 2024 Apr 9:132035. doi: 10.1016/j.ijcard.2024.132035.
     

     >> Share

     
     
402. YILDIRIM M, Giannitsis E, Mueller-Hennessen M
     Reply to: Kavsak et al. The clinical chemistry score (CCS) achieves the highest efficacy when assessed with the 99% sensitivity benchmark for myocardial infarction.
     Int J Cardiol. 2024 Apr 6:132030. doi: 10.1016/j.ijcard.2024.132030.
     

     >> Share

     
     
403. PETERSEN JK, Butt JH, Yafasova A, Torp-Pedersen C, et al
     Prognosis and antithrombotic practice patterns in patients with recurrent and transient atrial fibrillation following acute coronary syndrome: A nationwide study.
     Int J Cardiol. 2024 Apr 6:132017. doi: 10.1016/j.ijcard.2024.132017.
     

     >> Share

     
     March 2024
404. CHENG Y, Zhang Q
     Comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
     Int J Cardiol. 2024 Mar 26:131979. doi: 10.1016/j.ijcard.2024.131979.
     

     >> Share

     
     
405. PINGITORE A, Zhang C, Vassalle C, Ferragina P, et al
     Machine learning to identify a composite indicator to predict cardiac death in ischemic heart disease.
     Int J Cardiol. 2024 Mar 23:131981. doi: 10.1016/j.ijcard.2024.131981.
     

     >> Share

     
     
406. MCCORD J
     Identification and definition of type 2 myocardial infarction: Where do we go from here?
     Int J Cardiol. 2024 Mar 7:131941. doi: 10.1016/j.ijcard.2024.131941.
     

     >> Share

     
     
407. VAN DEN BROEK WWA, Gimbel ME, Hermanides RS, Runnett C, et al
     The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome.
     Int J Cardiol. 2024 Mar 7:131940. doi: 10.1016/j.ijcard.2024.131940.
     

     >> Share

     
     
408. GIACOBBE F, Giannino G, Annone U, Morena A, et al
     Impact of statin adherence and interruption within 6 months after ST-segment elevation myocardial infarction (STEMI): Results from the real-world regional registry FAST-STEMI.
     Int J Cardiol. 2024 Mar 2:131933. doi: 10.1016/j.ijcard.2024.131933.
     

     >> Share

     
     February 2024
409. POVLSEN AL, Helgestad OKL, Josiassen J, Christensen S, et al
     Invasive mechanical ventilation in cardiogenic shock complicating acute myocardial infarction: A contemporary Danish cohort analysis.
     Int J Cardiol. 2024 Feb 27:131910. doi: 10.1016/j.ijcard.2024.131910.
     

     >> Share

     
     
410. BOURG C, Lee KC, Donal E
     Understanding myocardial mechanics in primary mitral regurgitation: A contemporary approach.
     Int J Cardiol. 2024 Feb 17:131882. doi: 10.1016/j.ijcard.2024.131882.
     

     >> Share

     
     
411. BOERHOUT CKM, Vink CEM, Lee JM, de Waard GA, et al
     Impact of sex on the assessment of the microvascular resistance reserve.
     Int J Cardiol. 2024 Feb 3:131832. doi: 10.1016/j.ijcard.2024.131832.
     

     >> Share

     
     December 2023
412. BUJAK K, Rinaldi R, Vidal-Cales P, Montone RA, et al
     Immediate versus staged complete revascularization in acute coronary syndrome: A meta-analysis of randomized controlled trials.
     Int J Cardiol. 2023;393:131397.
     

     >> Share

     
     
413. LIU S, Wang P, Liu C, Jin M, et al
     Effect of PCSK9 antibodies on coronary plaque regression and stabilization derived from intravascular imaging in patients with coronary artery disease: A meta-analysis.
     Int J Cardiol. 2023;392:131330.
     

     >> Share

     
     
414. LI F, Peng J, Lu Y, Zhou M, et al
     Blockade of CXCR4 promotes macrophage autophagy through the PI3K/AKT/mTOR pathway to alleviate coronary heart disease.
     Int J Cardiol. 2023;392:131303.
     

     >> Share

     
     November 2023
415. WEIGHT N, Moledina S, Rashid M, Chew N, et al
     Temporal analysis of non-ST segment elevation-acute coronary syndrome (NSTEACS) outcomes in 'young' patients under the age of fifty: A nationwide cohort study.
     Int J Cardiol. 2023;391:131294.
     

     >> Share

     
     
416. KASKI JC, Lluch N, Lopez-Sendon JL, Gorog DA, et al
     Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trial.
     Int J Cardiol. 2023;391:131291.
     

     >> Share

     
     
417. KUZEMCZAK M, Lipiecki J, Jeyalan V, Farhat H, et al
     Clinical outcomes of coronary intravascular lithotripsy in patients with stent failure (COIL registry).
     Int J Cardiol. 2023;391:131274.
     

     >> Share

     
     
418. DE KONING MLY, Al Ali L, Bourgonje AR, Assa S, et al
     Associations of systemic oxidative stress with functional outcomes after ST-segment elevation myocardial infarction.
     Int J Cardiol. 2023;391:131214.
     

     >> Share

     
     October 2023
419. YIN ZY, Fu T, He SM, Fu L, et al
     16alpha-OHE1, a novel oestrogen metabolite, attenuates dysfunction of left ventricle contractility via regulation of autophagy after myocardial ischemia and reperfusion.
     Int J Cardiol. 2023;388:131123.
     

     >> Share

     
     September 2023
420. EMMERT-FEES KMF, Luhar S, O'Flaherty M, Kypridemos C, et al
     Forecasting the mortality burden of coronary heart disease and stroke in Germany: National trends and regional inequalities.
     Int J Cardiol. 2023 Sep 25:131359. doi: 10.1016/j.ijcard.2023.131359.
     

     >> Share

     
     
421. FONDERICO C, Pergola V, Faccenda D, Salucci A, et al
     Impact of sacubitril/valsartan and gliflozins on cardiac resynchronization therapy response in ischemic and non-ischemic heart failure patients.
     Int J Cardiol. 2023 Sep 23:131391. doi: 10.1016/j.ijcard.2023.131391.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share